DeathSexSexDesc,DeathYearYear,DeathCOD113ICDCode113Desc,Deaths,DeathAgeAdjustedRate11,SORT
Female,2020 **,Salmonella infections (A01-A02),2,N/A,0
Female,2021 **,Salmonella infections (A01-A02),0,N/A,3
Female,Total,Salmonella infections (A01-A02),2,N/A,6
Male,2020 **,Salmonella infections (A01-A02),1,N/A,9
Male,2021 **,Salmonella infections (A01-A02),0,N/A,12
Male,Total,Salmonella infections (A01-A02),1,N/A,15
Unknown,2020 **,Salmonella infections (A01-A02),0,N/A,18
Unknown,2021 **,Salmonella infections (A01-A02),0,N/A,21
Unknown,Total,Salmonella infections (A01-A02),0,N/A,24
Total,2020 **,Salmonella infections (A01-A02),3,N/A,27
Total,2021 **,Salmonella infections (A01-A02),0,N/A,30
Total,Total,Salmonella infections (A01-A02),3,N/A,33
Female,2020 **,Shigellosis and amebiasis (A03A06),1,N/A,36
Female,2021 **,Shigellosis and amebiasis (A03A06),0,N/A,39
Female,Total,Shigellosis and amebiasis (A03A06),1,N/A,42
Male,2020 **,Shigellosis and amebiasis (A03A06),0,N/A,45
Male,2021 **,Shigellosis and amebiasis (A03A06),0,N/A,48
Male,Total,Shigellosis and amebiasis (A03A06),0,N/A,51
Unknown,2020 **,Shigellosis and amebiasis (A03A06),0,N/A,54
Unknown,2021 **,Shigellosis and amebiasis (A03A06),0,N/A,57
Unknown,Total,Shigellosis and amebiasis (A03A06),0,N/A,60
Total,2020 **,Shigellosis and amebiasis (A03A06),1,N/A,63
Total,2021 **,Shigellosis and amebiasis (A03A06),0,N/A,66
Total,Total,Shigellosis and amebiasis (A03A06),1,N/A,69
Female,2020 **,Certain other intestinal infections (A04A07-A09),151,1.7,72
Female,2021 **,Certain other intestinal infections (A04A07-A09),0,N/A,75
Female,Total,Certain other intestinal infections (A04A07-A09),151,0.8,78
Male,2020 **,Certain other intestinal infections (A04A07-A09),95,1.5,81
Male,2021 **,Certain other intestinal infections (A04A07-A09),0,N/A,84
Male,Total,Certain other intestinal infections (A04A07-A09),95,0.7,87
Unknown,2020 **,Certain other intestinal infections (A04A07-A09),0,N/A,90
Unknown,2021 **,Certain other intestinal infections (A04A07-A09),0,N/A,93
Unknown,Total,Certain other intestinal infections (A04A07-A09),0,N/A,96
Total,2020 **,Certain other intestinal infections (A04A07-A09),246,1.6,99
Total,2021 **,Certain other intestinal infections (A04A07-A09),0,N/A,102
Total,Total,Certain other intestinal infections (A04A07-A09),246,0.8,105
Female,2020 **,Respiratory tuberculosis (A16),4,N/A,108
Female,2021 **,Respiratory tuberculosis (A16),0,N/A,111
Female,Total,Respiratory tuberculosis (A16),4,N/A,114
Male,2020 **,Respiratory tuberculosis (A16),4,N/A,117
Male,2021 **,Respiratory tuberculosis (A16),0,N/A,120
Male,Total,Respiratory tuberculosis (A16),4,N/A,123
Unknown,2020 **,Respiratory tuberculosis (A16),0,N/A,126
Unknown,2021 **,Respiratory tuberculosis (A16),0,N/A,129
Unknown,Total,Respiratory tuberculosis (A16),0,N/A,132
Total,2020 **,Respiratory tuberculosis (A16),8,N/A,135
Total,2021 **,Respiratory tuberculosis (A16),0,N/A,138
Total,Total,Respiratory tuberculosis (A16),8,N/A,141
Female,2020 **,Other tuberculosis (A17-A19),1,N/A,144
Female,2021 **,Other tuberculosis (A17-A19),0,N/A,147
Female,Total,Other tuberculosis (A17-A19),1,N/A,150
Male,2020 **,Other tuberculosis (A17-A19),5,N/A,153
Male,2021 **,Other tuberculosis (A17-A19),0,N/A,156
Male,Total,Other tuberculosis (A17-A19),5,N/A,159
Unknown,2020 **,Other tuberculosis (A17-A19),0,N/A,162
Unknown,2021 **,Other tuberculosis (A17-A19),0,N/A,165
Unknown,Total,Other tuberculosis (A17-A19),0,N/A,168
Total,2020 **,Other tuberculosis (A17-A19),6,N/A,171
Total,2021 **,Other tuberculosis (A17-A19),0,N/A,174
Total,Total,Other tuberculosis (A17-A19),6,N/A,177
Female,2020 **,Whooping cough (A37),0,N/A,180
Female,2021 **,Whooping cough (A37),0,N/A,183
Female,Total,Whooping cough (A37),0,N/A,186
Male,2020 **,Whooping cough (A37),1,N/A,189
Male,2021 **,Whooping cough (A37),0,N/A,192
Male,Total,Whooping cough (A37),1,N/A,195
Unknown,2020 **,Whooping cough (A37),0,N/A,198
Unknown,2021 **,Whooping cough (A37),0,N/A,201
Unknown,Total,Whooping cough (A37),0,N/A,204
Total,2020 **,Whooping cough (A37),1,N/A,207
Total,2021 **,Whooping cough (A37),0,N/A,210
Total,Total,Whooping cough (A37),1,N/A,213
Female,2020 **,Scarlet fever and erysipelas (A38A46),0,N/A,216
Female,2021 **,Scarlet fever and erysipelas (A38A46),0,N/A,219
Female,Total,Scarlet fever and erysipelas (A38A46),0,N/A,222
Male,2020 **,Scarlet fever and erysipelas (A38A46),0,N/A,225
Male,2021 **,Scarlet fever and erysipelas (A38A46),0,N/A,228
Male,Total,Scarlet fever and erysipelas (A38A46),0,N/A,231
Unknown,2020 **,Scarlet fever and erysipelas (A38A46),0,N/A,234
Unknown,2021 **,Scarlet fever and erysipelas (A38A46),0,N/A,237
Unknown,Total,Scarlet fever and erysipelas (A38A46),0,N/A,240
Total,2020 **,Scarlet fever and erysipelas (A38A46),0,N/A,243
Total,2021 **,Scarlet fever and erysipelas (A38A46),0,N/A,246
Total,Total,Scarlet fever and erysipelas (A38A46),0,N/A,249
Female,2020 **,Meningococcal infection (A39),0,N/A,252
Female,2021 **,Meningococcal infection (A39),0,N/A,255
Female,Total,Meningococcal infection (A39),0,N/A,258
Male,2020 **,Meningococcal infection (A39),1,N/A,261
Male,2021 **,Meningococcal infection (A39),0,N/A,264
Male,Total,Meningococcal infection (A39),1,N/A,267
Unknown,2020 **,Meningococcal infection (A39),0,N/A,270
Unknown,2021 **,Meningococcal infection (A39),0,N/A,273
Unknown,Total,Meningococcal infection (A39),0,N/A,276
Total,2020 **,Meningococcal infection (A39),1,N/A,279
Total,2021 **,Meningococcal infection (A39),0,N/A,282
Total,Total,Meningococcal infection (A39),1,N/A,285
Female,2020 **,Septicemia (A40-A41),1005,11.7,288
Female,2021 **,Septicemia (A40-A41),0,N/A,291
Female,Total,Septicemia (A40-A41),1005,5.8,294
Male,2020 **,Septicemia (A40-A41),872,13.2,297
Male,2021 **,Septicemia (A40-A41),3,N/A,300
Male,Total,Septicemia (A40-A41),875,6.6,303
Unknown,2020 **,Septicemia (A40-A41),0,N/A,306
Unknown,2021 **,Septicemia (A40-A41),0,N/A,309
Unknown,Total,Septicemia (A40-A41),0,N/A,312
Total,2020 **,Septicemia (A40-A41),1877,12.3,315
Total,2021 **,Septicemia (A40-A41),3,N/A,318
Total,Total,Septicemia (A40-A41),1880,6.2,321
Female,2020 **,Syphilis ((A50-A53),0,N/A,324
Female,2021 **,Syphilis ((A50-A53),0,N/A,327
Female,Total,Syphilis ((A50-A53),0,N/A,330
Male,2020 **,Syphilis ((A50-A53),1,N/A,333
Male,2021 **,Syphilis ((A50-A53),0,N/A,336
Male,Total,Syphilis ((A50-A53),1,N/A,339
Unknown,2020 **,Syphilis ((A50-A53),0,N/A,342
Unknown,2021 **,Syphilis ((A50-A53),0,N/A,345
Unknown,Total,Syphilis ((A50-A53),0,N/A,348
Total,2020 **,Syphilis ((A50-A53),1,N/A,351
Total,2021 **,Syphilis ((A50-A53),0,N/A,354
Total,Total,Syphilis ((A50-A53),1,N/A,357
Female,2020 **,Acute poliomyelitis (A80),0,N/A,360
Female,2021 **,Acute poliomyelitis (A80),0,N/A,363
Female,Total,Acute poliomyelitis (A80),0,N/A,366
Male,2020 **,Acute poliomyelitis (A80),0,N/A,369
Male,2021 **,Acute poliomyelitis (A80),0,N/A,372
Male,Total,Acute poliomyelitis (A80),0,N/A,375
Unknown,2020 **,Acute poliomyelitis (A80),0,N/A,378
Unknown,2021 **,Acute poliomyelitis (A80),0,N/A,381
Unknown,Total,Acute poliomyelitis (A80),0,N/A,384
Total,2020 **,Acute poliomyelitis (A80),0,N/A,387
Total,2021 **,Acute poliomyelitis (A80),0,N/A,390
Total,Total,Acute poliomyelitis (A80),0,N/A,393
Female,2020 **,Arthropod-borne viral encephalitis (A83-A84A85.2),0,N/A,396
Female,2021 **,Arthropod-borne viral encephalitis (A83-A84A85.2),0,N/A,399
Female,Total,Arthropod-borne viral encephalitis (A83-A84A85.2),0,N/A,402
Male,2020 **,Arthropod-borne viral encephalitis (A83-A84A85.2),0,N/A,405
Male,2021 **,Arthropod-borne viral encephalitis (A83-A84A85.2),0,N/A,408
Male,Total,Arthropod-borne viral encephalitis (A83-A84A85.2),0,N/A,411
Unknown,2020 **,Arthropod-borne viral encephalitis (A83-A84A85.2),0,N/A,414
Unknown,2021 **,Arthropod-borne viral encephalitis (A83-A84A85.2),0,N/A,417
Unknown,Total,Arthropod-borne viral encephalitis (A83-A84A85.2),0,N/A,420
Total,2020 **,Arthropod-borne viral encephalitis (A83-A84A85.2),0,N/A,423
Total,2021 **,Arthropod-borne viral encephalitis (A83-A84A85.2),0,N/A,426
Total,Total,Arthropod-borne viral encephalitis (A83-A84A85.2),0,N/A,429
Female,2020 **,Viral hepatitis (B15-B19),30,0.4,432
Female,2021 **,Viral hepatitis (B15-B19),0,N/A,435
Female,Total,Viral hepatitis (B15-B19),30,0.2,438
Male,2020 **,Viral hepatitis (B15-B19),67,0.9,441
Male,2021 **,Viral hepatitis (B15-B19),0,N/A,444
Male,Total,Viral hepatitis (B15-B19),67,0.5,447
Unknown,2020 **,Viral hepatitis (B15-B19),0,N/A,450
Unknown,2021 **,Viral hepatitis (B15-B19),0,N/A,453
Unknown,Total,Viral hepatitis (B15-B19),0,N/A,456
Total,2020 **,Viral hepatitis (B15-B19),97,0.7,459
Total,2021 **,Viral hepatitis (B15-B19),0,N/A,462
Total,Total,Viral hepatitis (B15-B19),97,0.3,465
Female,2020 **,Human immunodeficiency virus (HIV) disease (B20-B24),17,0.3,468
Female,2021 **,Human immunodeficiency virus (HIV) disease (B20-B24),0,N/A,471
Female,Total,Human immunodeficiency virus (HIV) disease (B20-B24),17,0.1,474
Male,2020 **,Human immunodeficiency virus (HIV) disease (B20-B24),69,1.1,477
Male,2021 **,Human immunodeficiency virus (HIV) disease (B20-B24),0,N/A,480
Male,Total,Human immunodeficiency virus (HIV) disease (B20-B24),69,0.5,483
Unknown,2020 **,Human immunodeficiency virus (HIV) disease (B20-B24),0,N/A,486
Unknown,2021 **,Human immunodeficiency virus (HIV) disease (B20-B24),0,N/A,489
Unknown,Total,Human immunodeficiency virus (HIV) disease (B20-B24),0,N/A,492
Total,2020 **,Human immunodeficiency virus (HIV) disease (B20-B24),86,0.7,495
Total,2021 **,Human immunodeficiency virus (HIV) disease (B20-B24),0,N/A,498
Total,Total,Human immunodeficiency virus (HIV) disease (B20-B24),86,0.3,501
Female,2020 **,Malaria (B50-B54),0,N/A,504
Female,2021 **,Malaria (B50-B54),0,N/A,507
Female,Total,Malaria (B50-B54),0,N/A,510
Male,2020 **,Malaria (B50-B54),0,N/A,513
Male,2021 **,Malaria (B50-B54),0,N/A,516
Male,Total,Malaria (B50-B54),0,N/A,519
Unknown,2020 **,Malaria (B50-B54),0,N/A,522
Unknown,2021 **,Malaria (B50-B54),0,N/A,525
Unknown,Total,Malaria (B50-B54),0,N/A,528
Total,2020 **,Malaria (B50-B54),0,N/A,531
Total,2021 **,Malaria (B50-B54),0,N/A,534
Total,Total,Malaria (B50-B54),0,N/A,537
Female,2020 **,Other and unspecified infectious and parasitic diseases and their sequelae (A00A05A20-A36A42-A44A48-A49A54-A79A81-A82A85.0-A85.1A85.8A86-B04B06-B09B25-B49B55-B99),170,2.1,540
Female,2021 **,Other and unspecified infectious and parasitic diseases and their sequelae (A00A05A20-A36A42-A44A48-A49A54-A79A81-A82A85.0-A85.1A85.8A86-B04B06-B09B25-B49B55-B99),0,N/A,543
Female,Total,Other and unspecified infectious and parasitic diseases and their sequelae (A00A05A20-A36A42-A44A48-A49A54-A79A81-A82A85.0-A85.1A85.8A86-B04B06-B09B25-B49B55-B99),170,1.0,546
Male,2020 **,Other and unspecified infectious and parasitic diseases and their sequelae (A00A05A20-A36A42-A44A48-A49A54-A79A81-A82A85.0-A85.1A85.8A86-B04B06-B09B25-B49B55-B99),200,3.1,549
Male,2021 **,Other and unspecified infectious and parasitic diseases and their sequelae (A00A05A20-A36A42-A44A48-A49A54-A79A81-A82A85.0-A85.1A85.8A86-B04B06-B09B25-B49B55-B99),0,N/A,552
Male,Total,Other and unspecified infectious and parasitic diseases and their sequelae (A00A05A20-A36A42-A44A48-A49A54-A79A81-A82A85.0-A85.1A85.8A86-B04B06-B09B25-B49B55-B99),200,1.5,555
Unknown,2020 **,Other and unspecified infectious and parasitic diseases and their sequelae (A00A05A20-A36A42-A44A48-A49A54-A79A81-A82A85.0-A85.1A85.8A86-B04B06-B09B25-B49B55-B99),0,N/A,558
Unknown,2021 **,Other and unspecified infectious and parasitic diseases and their sequelae (A00A05A20-A36A42-A44A48-A49A54-A79A81-A82A85.0-A85.1A85.8A86-B04B06-B09B25-B49B55-B99),0,N/A,561
Unknown,Total,Other and unspecified infectious and parasitic diseases and their sequelae (A00A05A20-A36A42-A44A48-A49A54-A79A81-A82A85.0-A85.1A85.8A86-B04B06-B09B25-B49B55-B99),0,N/A,564
Total,2020 **,Other and unspecified infectious and parasitic diseases and their sequelae (A00A05A20-A36A42-A44A48-A49A54-A79A81-A82A85.0-A85.1A85.8A86-B04B06-B09B25-B49B55-B99),370,2.5,567
Total,2021 **,Other and unspecified infectious and parasitic diseases and their sequelae (A00A05A20-A36A42-A44A48-A49A54-A79A81-A82A85.0-A85.1A85.8A86-B04B06-B09B25-B49B55-B99),0,N/A,570
Total,Total,Other and unspecified infectious and parasitic diseases and their sequelae (A00A05A20-A36A42-A44A48-A49A54-A79A81-A82A85.0-A85.1A85.8A86-B04B06-B09B25-B49B55-B99),370,1.3,573
Female,2020 **,Malignant neoplasms of lip oral cavity and pharynx (C00-C14),128,1.6,576
Female,2021 **,Malignant neoplasms of lip oral cavity and pharynx (C00-C14),0,N/A,579
Female,Total,Malignant neoplasms of lip oral cavity and pharynx (C00-C14),128,0.8,582
Male,2020 **,Malignant neoplasms of lip oral cavity and pharynx (C00-C14),323,4.5,585
Male,2021 **,Malignant neoplasms of lip oral cavity and pharynx (C00-C14),1,N/A,588
Male,Total,Malignant neoplasms of lip oral cavity and pharynx (C00-C14),324,2.2,591
Unknown,2020 **,Malignant neoplasms of lip oral cavity and pharynx (C00-C14),0,N/A,594
Unknown,2021 **,Malignant neoplasms of lip oral cavity and pharynx (C00-C14),0,N/A,597
Unknown,Total,Malignant neoplasms of lip oral cavity and pharynx (C00-C14),0,N/A,600
Total,2020 **,Malignant neoplasms of lip oral cavity and pharynx (C00-C14),451,2.9,603
Total,2021 **,Malignant neoplasms of lip oral cavity and pharynx (C00-C14),1,N/A,606
Total,Total,Malignant neoplasms of lip oral cavity and pharynx (C00-C14),452,1.4,609
Female,2020 **,Malignant neoplasm of esophagus (C15),104,1.2,612
Female,2021 **,Malignant neoplasm of esophagus (C15),1,N/A,615
Female,Total,Malignant neoplasm of esophagus (C15),105,0.6,618
Male,2020 **,Malignant neoplasm of esophagus (C15),521,7.3,621
Male,2021 **,Malignant neoplasm of esophagus (C15),1,N/A,624
Male,Total,Malignant neoplasm of esophagus (C15),522,3.6,627
Unknown,2020 **,Malignant neoplasm of esophagus (C15),0,N/A,630
Unknown,2021 **,Malignant neoplasm of esophagus (C15),0,N/A,633
Unknown,Total,Malignant neoplasm of esophagus (C15),0,N/A,636
Total,2020 **,Malignant neoplasm of esophagus (C15),625,4.0,639
Total,2021 **,Malignant neoplasm of esophagus (C15),2,N/A,642
Total,Total,Malignant neoplasm of esophagus (C15),627,2.0,645
Female,2020 **,Malignant neoplasm of stomach (C16),143,1.7,648
Female,2021 **,Malignant neoplasm of stomach (C16),0,N/A,651
Female,Total,Malignant neoplasm of stomach (C16),143,0.9,654
Male,2020 **,Malignant neoplasm of stomach (C16),181,2.6,657
Male,2021 **,Malignant neoplasm of stomach (C16),0,N/A,660
Male,Total,Malignant neoplasm of stomach (C16),181,1.3,663
Unknown,2020 **,Malignant neoplasm of stomach (C16),0,N/A,666
Unknown,2021 **,Malignant neoplasm of stomach (C16),0,N/A,669
Unknown,Total,Malignant neoplasm of stomach (C16),0,N/A,672
Total,2020 **,Malignant neoplasm of stomach (C16),324,2.1,675
Total,2021 **,Malignant neoplasm of stomach (C16),0,N/A,678
Total,Total,Malignant neoplasm of stomach (C16),324,1.1,681
Female,2020 **,Malignant neoplasms of colon rectum and anus (C18-C21),936,11.0,684
Female,2021 **,Malignant neoplasms of colon rectum and anus (C18-C21),6,N/A,687
Female,Total,Malignant neoplasms of colon rectum and anus (C18-C21),942,5.5,690
Male,2020 **,Malignant neoplasms of colon rectum and anus (C18-C21),1043,15.4,693
Male,2021 **,Malignant neoplasms of colon rectum and anus (C18-C21),4,N/A,696
Male,Total,Malignant neoplasms of colon rectum and anus (C18-C21),1047,7.8,699
Unknown,2020 **,Malignant neoplasms of colon rectum and anus (C18-C21),0,N/A,702
Unknown,2021 **,Malignant neoplasms of colon rectum and anus (C18-C21),0,N/A,705
Unknown,Total,Malignant neoplasms of colon rectum and anus (C18-C21),0,N/A,708
Total,2020 **,Malignant neoplasms of colon rectum and anus (C18-C21),1979,13.0,711
Total,2021 **,Malignant neoplasms of colon rectum and anus (C18-C21),10,0.1,714
Total,Total,Malignant neoplasms of colon rectum and anus (C18-C21),1989,6.6,717
Female,2020 **,Malignant neoplasms of liver and intrahepatic bile ducts (C22),312,3.7,720
Female,2021 **,Malignant neoplasms of liver and intrahepatic bile ducts (C22),0,N/A,723
Female,Total,Malignant neoplasms of liver and intrahepatic bile ducts (C22),312,1.8,726
Male,2020 **,Malignant neoplasms of liver and intrahepatic bile ducts (C22),585,8.0,729
Male,2021 **,Malignant neoplasms of liver and intrahepatic bile ducts (C22),0,N/A,732
Male,Total,Malignant neoplasms of liver and intrahepatic bile ducts (C22),585,4.0,735
Unknown,2020 **,Malignant neoplasms of liver and intrahepatic bile ducts (C22),0,N/A,738
Unknown,2021 **,Malignant neoplasms of liver and intrahepatic bile ducts (C22),0,N/A,741
Unknown,Total,Malignant neoplasms of liver and intrahepatic bile ducts (C22),0,N/A,744
Total,2020 **,Malignant neoplasms of liver and intrahepatic bile ducts (C22),897,5.6,747
Total,2021 **,Malignant neoplasms of liver and intrahepatic bile ducts (C22),0,N/A,750
Total,Total,Malignant neoplasms of liver and intrahepatic bile ducts (C22),897,2.8,753
Female,2020 **,Malignant neoplasm of pancreas (C25),819,9.4,756
Female,2021 **,Malignant neoplasm of pancreas (C25),3,N/A,759
Female,Total,Malignant neoplasm of pancreas (C25),822,4.7,762
Male,2020 **,Malignant neoplasm of pancreas (C25),905,13.0,765
Male,2021 **,Malignant neoplasm of pancreas (C25),1,N/A,768
Male,Total,Malignant neoplasm of pancreas (C25),906,6.5,771
Unknown,2020 **,Malignant neoplasm of pancreas (C25),0,N/A,774
Unknown,2021 **,Malignant neoplasm of pancreas (C25),0,N/A,777
Unknown,Total,Malignant neoplasm of pancreas (C25),0,N/A,780
Total,2020 **,Malignant neoplasm of pancreas (C25),1724,11.0,783
Total,2021 **,Malignant neoplasm of pancreas (C25),4,N/A,786
Total,Total,Malignant neoplasm of pancreas (C25),1728,5.5,789
Female,2020 **,Malignant neoplasm of larynx (C32),33,0.4,792
Female,2021 **,Malignant neoplasm of larynx (C32),0,N/A,795
Female,Total,Malignant neoplasm of larynx (C32),33,0.2,798
Male,2020 **,Malignant neoplasm of larynx (C32),134,1.8,801
Male,2021 **,Malignant neoplasm of larynx (C32),0,N/A,804
Male,Total,Malignant neoplasm of larynx (C32),134,0.9,807
Unknown,2020 **,Malignant neoplasm of larynx (C32),0,N/A,810
Unknown,2021 **,Malignant neoplasm of larynx (C32),0,N/A,813
Unknown,Total,Malignant neoplasm of larynx (C32),0,N/A,816
Total,2020 **,Malignant neoplasm of larynx (C32),167,1.0,819
Total,2021 **,Malignant neoplasm of larynx (C32),0,N/A,822
Total,Total,Malignant neoplasm of larynx (C32),167,0.5,825
Female,2020 **,Malignant neoplasms of trachea bronchus and lung (C33-C34),2596,29.7,828
Female,2021 **,Malignant neoplasms of trachea bronchus and lung (C33-C34),6,N/A,831
Female,Total,Malignant neoplasms of trachea bronchus and lung (C33-C34),2602,14.9,834
Male,2020 **,Malignant neoplasms of trachea bronchus and lung (C33-C34),3129,44.4,837
Male,2021 **,Malignant neoplasms of trachea bronchus and lung (C33-C34),4,N/A,840
Male,Total,Malignant neoplasms of trachea bronchus and lung (C33-C34),3133,22.2,843
Unknown,2020 **,Malignant neoplasms of trachea bronchus and lung (C33-C34),0,N/A,846
Unknown,2021 **,Malignant neoplasms of trachea bronchus and lung (C33-C34),0,N/A,849
Unknown,Total,Malignant neoplasms of trachea bronchus and lung (C33-C34),0,N/A,852
Total,2020 **,Malignant neoplasms of trachea bronchus and lung (C33-C34),5725,36.1,855
Total,2021 **,Malignant neoplasms of trachea bronchus and lung (C33-C34),10,0.1,858
Total,Total,Malignant neoplasms of trachea bronchus and lung (C33-C34),5735,18.1,861
Female,2020 **,Malignant melanoma of skin (C43),110,1.4,864
Female,2021 **,Malignant melanoma of skin (C43),2,N/A,867
Female,Total,Malignant melanoma of skin (C43),112,0.7,870
Male,2020 **,Malignant melanoma of skin (C43),247,3.7,873
Male,2021 **,Malignant melanoma of skin (C43),0,N/A,876
Male,Total,Malignant melanoma of skin (C43),247,1.9,879
Unknown,2020 **,Malignant melanoma of skin (C43),0,N/A,882
Unknown,2021 **,Malignant melanoma of skin (C43),0,N/A,885
Unknown,Total,Malignant melanoma of skin (C43),0,N/A,888
Total,2020 **,Malignant melanoma of skin (C43),357,2.4,891
Total,2021 **,Malignant melanoma of skin (C43),2,N/A,894
Total,Total,Malignant melanoma of skin (C43),359,1.2,897
Female,2020 **,Malignant neoplasm of breast (C50),1522,18.4,900
Female,2021 **,Malignant neoplasm of breast (C50),3,N/A,903
Female,Total,Malignant neoplasm of breast (C50),1525,9.2,906
Male,2020 **,Malignant neoplasm of breast (C50),20,0.3,909
Male,2021 **,Malignant neoplasm of breast (C50),0,N/A,912
Male,Total,Malignant neoplasm of breast (C50),20,0.2,915
Unknown,2020 **,Malignant neoplasm of breast (C50),0,N/A,918
Unknown,2021 **,Malignant neoplasm of breast (C50),0,N/A,921
Unknown,Total,Malignant neoplasm of breast (C50),0,N/A,924
Total,2020 **,Malignant neoplasm of breast (C50),1542,10.3,927
Total,2021 **,Malignant neoplasm of breast (C50),3,N/A,930
Total,Total,Malignant neoplasm of breast (C50),1545,5.2,933
Female,2020 **,Malignant neoplasm of cervix uteri (C53),134,2.0,936
Female,2021 **,Malignant neoplasm of cervix uteri (C53),0,N/A,939
Female,Total,Malignant neoplasm of cervix uteri (C53),134,1.0,942
Male,2020 **,Malignant neoplasm of cervix uteri (C53),0,N/A,945
Male,2021 **,Malignant neoplasm of cervix uteri (C53),0,N/A,948
Male,Total,Malignant neoplasm of cervix uteri (C53),0,N/A,951
Unknown,2020 **,Malignant neoplasm of cervix uteri (C53),0,N/A,954
Unknown,2021 **,Malignant neoplasm of cervix uteri (C53),0,N/A,957
Unknown,Total,Malignant neoplasm of cervix uteri (C53),0,N/A,960
Total,2020 **,Malignant neoplasm of cervix uteri (C53),134,1.0,963
Total,2021 **,Malignant neoplasm of cervix uteri (C53),0,N/A,966
Total,Total,Malignant neoplasm of cervix uteri (C53),134,0.5,969
Female,2020 **,Malignant neoplasms of corpus uteri and uterus part unspecified (C54-C55),437,4.9,972
Female,2021 **,Malignant neoplasms of corpus uteri and uterus part unspecified (C54-C55),2,N/A,975
Female,Total,Malignant neoplasms of corpus uteri and uterus part unspecified (C54-C55),439,2.5,978
Male,2020 **,Malignant neoplasms of corpus uteri and uterus part unspecified (C54-C55),0,N/A,981
Male,2021 **,Malignant neoplasms of corpus uteri and uterus part unspecified (C54-C55),0,N/A,984
Male,Total,Malignant neoplasms of corpus uteri and uterus part unspecified (C54-C55),0,N/A,987
Unknown,2020 **,Malignant neoplasms of corpus uteri and uterus part unspecified (C54-C55),0,N/A,990
Unknown,2021 **,Malignant neoplasms of corpus uteri and uterus part unspecified (C54-C55),0,N/A,993
Unknown,Total,Malignant neoplasms of corpus uteri and uterus part unspecified (C54-C55),0,N/A,996
Total,2020 **,Malignant neoplasms of corpus uteri and uterus part unspecified (C54-C55),437,2.7,999
Total,2021 **,Malignant neoplasms of corpus uteri and uterus part unspecified (C54-C55),2,N/A,1002
Total,Total,Malignant neoplasms of corpus uteri and uterus part unspecified (C54-C55),439,1.4,1005
Female,2020 **,Malignant neoplasm of ovary (C56),441,5.2,1008
Female,2021 **,Malignant neoplasm of ovary (C56),1,N/A,1011
Female,Total,Malignant neoplasm of ovary (C56),442,2.6,1014
Male,2020 **,Malignant neoplasm of ovary (C56),0,N/A,1017
Male,2021 **,Malignant neoplasm of ovary (C56),0,N/A,1020
Male,Total,Malignant neoplasm of ovary (C56),0,N/A,1023
Unknown,2020 **,Malignant neoplasm of ovary (C56),0,N/A,1026
Unknown,2021 **,Malignant neoplasm of ovary (C56),0,N/A,1029
Unknown,Total,Malignant neoplasm of ovary (C56),0,N/A,1032
Total,2020 **,Malignant neoplasm of ovary (C56),441,2.8,1035
Total,2021 **,Malignant neoplasm of ovary (C56),1,N/A,1038
Total,Total,Malignant neoplasm of ovary (C56),442,1.4,1041
Female,2020 **,Malignant neoplasm of prostate (C61),0,N/A,1044
Female,2021 **,Malignant neoplasm of prostate (C61),0,N/A,1047
Female,Total,Malignant neoplasm of prostate (C61),0,N/A,1050
Male,2020 **,Malignant neoplasm of prostate (C61),1113,17.2,1053
Male,2021 **,Malignant neoplasm of prostate (C61),2,N/A,1056
Male,Total,Malignant neoplasm of prostate (C61),1115,8.6,1059
Unknown,2020 **,Malignant neoplasm of prostate (C61),0,N/A,1062
Unknown,2021 **,Malignant neoplasm of prostate (C61),0,N/A,1065
Unknown,Total,Malignant neoplasm of prostate (C61),0,N/A,1068
Total,2020 **,Malignant neoplasm of prostate (C61),1113,7.1,1071
Total,2021 **,Malignant neoplasm of prostate (C61),2,N/A,1074
Total,Total,Malignant neoplasm of prostate (C61),1115,3.5,1077
Female,2020 **,Malignant neoplasms of kidney and renal pelvis (C64-C65),193,2.3,1080
Female,2021 **,Malignant neoplasms of kidney and renal pelvis (C64-C65),0,N/A,1083
Female,Total,Malignant neoplasms of kidney and renal pelvis (C64-C65),193,1.1,1086
Male,2020 **,Malignant neoplasms of kidney and renal pelvis (C64-C65),359,5.3,1089
Male,2021 **,Malignant neoplasms of kidney and renal pelvis (C64-C65),1,N/A,1092
Male,Total,Malignant neoplasms of kidney and renal pelvis (C64-C65),360,2.6,1095
Unknown,2020 **,Malignant neoplasms of kidney and renal pelvis (C64-C65),0,N/A,1098
Unknown,2021 **,Malignant neoplasms of kidney and renal pelvis (C64-C65),0,N/A,1101
Unknown,Total,Malignant neoplasms of kidney and renal pelvis (C64-C65),0,N/A,1104
Total,2020 **,Malignant neoplasms of kidney and renal pelvis (C64-C65),552,3.6,1107
Total,2021 **,Malignant neoplasms of kidney and renal pelvis (C64-C65),1,N/A,1110
Total,Total,Malignant neoplasms of kidney and renal pelvis (C64-C65),553,1.8,1113
Female,2020 **,Malignant neoplasm of bladder (C67),187,2.1,1116
Female,2021 **,Malignant neoplasm of bladder (C67),0,N/A,1119
Female,Total,Malignant neoplasm of bladder (C67),187,1.1,1122
Male,2020 **,Malignant neoplasm of bladder (C67),515,8.0,1125
Male,2021 **,Malignant neoplasm of bladder (C67),0,N/A,1128
Male,Total,Malignant neoplasm of bladder (C67),515,4.0,1131
Unknown,2020 **,Malignant neoplasm of bladder (C67),0,N/A,1134
Unknown,2021 **,Malignant neoplasm of bladder (C67),0,N/A,1137
Unknown,Total,Malignant neoplasm of bladder (C67),0,N/A,1140
Total,2020 **,Malignant neoplasm of bladder (C67),702,4.5,1143
Total,2021 **,Malignant neoplasm of bladder (C67),0,N/A,1146
Total,Total,Malignant neoplasm of bladder (C67),702,2.3,1149
Female,2020 **,Malignant neoplasms of meninges brain and other parts of central nervous system (C70-C72),255,3.3,1152
Female,2021 **,Malignant neoplasms of meninges brain and other parts of central nervous system (C70-C72),1,N/A,1155
Female,Total,Malignant neoplasms of meninges brain and other parts of central nervous system (C70-C72),256,1.7,1158
Male,2020 **,Malignant neoplasms of meninges brain and other parts of central nervous system (C70-C72),366,5.4,1161
Male,2021 **,Malignant neoplasms of meninges brain and other parts of central nervous system (C70-C72),3,N/A,1164
Male,Total,Malignant neoplasms of meninges brain and other parts of central nervous system (C70-C72),369,2.7,1167
Unknown,2020 **,Malignant neoplasms of meninges brain and other parts of central nervous system (C70-C72),0,N/A,1170
Unknown,2021 **,Malignant neoplasms of meninges brain and other parts of central nervous system (C70-C72),0,N/A,1173
Unknown,Total,Malignant neoplasms of meninges brain and other parts of central nervous system (C70-C72),0,N/A,1176
Total,2020 **,Malignant neoplasms of meninges brain and other parts of central nervous system (C70-C72),621,4.3,1179
Total,2021 **,Malignant neoplasms of meninges brain and other parts of central nervous system (C70-C72),4,N/A,1182
Total,Total,Malignant neoplasms of meninges brain and other parts of central nervous system (C70-C72),625,2.2,1185
Female,2020 **,Hodgkin's disease (C81),13,0.1,1188
Female,2021 **,Hodgkin's disease (C81),0,N/A,1191
Female,Total,Hodgkin's disease (C81),13,0.1,1194
Male,2020 **,Hodgkin's disease (C81),25,0.4,1197
Male,2021 **,Hodgkin's disease (C81),0,N/A,1200
Male,Total,Hodgkin's disease (C81),25,0.2,1203
Unknown,2020 **,Hodgkin's disease (C81),0,N/A,1206
Unknown,2021 **,Hodgkin's disease (C81),0,N/A,1209
Unknown,Total,Hodgkin's disease (C81),0,N/A,1212
Total,2020 **,Hodgkin's disease (C81),38,0.3,1215
Total,2021 **,Hodgkin's disease (C81),0,N/A,1218
Total,Total,Hodgkin's disease (C81),38,0.1,1221
Female,2020 **,Non-Hodgkin's lymphoma (C82-C85),314,3.6,1224
Female,2021 **,Non-Hodgkin's lymphoma (C82-C85),2,N/A,1227
Female,Total,Non-Hodgkin's lymphoma (C82-C85),316,1.8,1230
Male,2020 **,Non-Hodgkin's lymphoma (C82-C85),455,6.9,1233
Male,2021 **,Non-Hodgkin's lymphoma (C82-C85),2,N/A,1236
Male,Total,Non-Hodgkin's lymphoma (C82-C85),457,3.5,1239
Unknown,2020 **,Non-Hodgkin's lymphoma (C82-C85),0,N/A,1242
Unknown,2021 **,Non-Hodgkin's lymphoma (C82-C85),0,N/A,1245
Unknown,Total,Non-Hodgkin's lymphoma (C82-C85),0,N/A,1248
Total,2020 **,Non-Hodgkin's lymphoma (C82-C85),769,5.0,1251
Total,2021 **,Non-Hodgkin's lymphoma (C82-C85),4,N/A,1254
Total,Total,Non-Hodgkin's lymphoma (C82-C85),773,2.5,1257
Female,2020 **,Leukemia (C91-C95),415,4.9,1260
Female,2021 **,Leukemia (C91-C95),3,N/A,1263
Female,Total,Leukemia (C91-C95),418,2.5,1266
Male,2020 **,Leukemia (C91-C95),484,7.4,1269
Male,2021 **,Leukemia (C91-C95),0,N/A,1272
Male,Total,Leukemia (C91-C95),484,3.7,1275
Unknown,2020 **,Leukemia (C91-C95),0,N/A,1278
Unknown,2021 **,Leukemia (C91-C95),0,N/A,1281
Unknown,Total,Leukemia (C91-C95),0,N/A,1284
Total,2020 **,Leukemia (C91-C95),899,6.0,1287
Total,2021 **,Leukemia (C91-C95),3,N/A,1290
Total,Total,Leukemia (C91-C95),902,3.0,1293
Female,2020 **,Multiple myeloma and immunoproliferative neoplasms (C88C90),230,2.6,1296
Female,2021 **,Multiple myeloma and immunoproliferative neoplasms (C88C90),2,N/A,1299
Female,Total,Multiple myeloma and immunoproliferative neoplasms (C88C90),232,1.3,1302
Male,2020 **,Multiple myeloma and immunoproliferative neoplasms (C88C90),274,4.0,1305
Male,2021 **,Multiple myeloma and immunoproliferative neoplasms (C88C90),1,N/A,1308
Male,Total,Multiple myeloma and immunoproliferative neoplasms (C88C90),275,2.0,1311
Unknown,2020 **,Multiple myeloma and immunoproliferative neoplasms (C88C90),0,N/A,1314
Unknown,2021 **,Multiple myeloma and immunoproliferative neoplasms (C88C90),0,N/A,1317
Unknown,Total,Multiple myeloma and immunoproliferative neoplasms (C88C90),0,N/A,1320
Total,2020 **,Multiple myeloma and immunoproliferative neoplasms (C88C90),504,3.2,1323
Total,2021 **,Multiple myeloma and immunoproliferative neoplasms (C88C90),3,N/A,1326
Total,Total,Multiple myeloma and immunoproliferative neoplasms (C88C90),507,1.6,1329
Female,2020 **,Other and unspecified malignant neoplasms of lymphoid hematopoietic and related tissue (C96),1,N/A,1332
Female,2021 **,Other and unspecified malignant neoplasms of lymphoid hematopoietic and related tissue (C96),0,N/A,1335
Female,Total,Other and unspecified malignant neoplasms of lymphoid hematopoietic and related tissue (C96),1,N/A,1338
Male,2020 **,Other and unspecified malignant neoplasms of lymphoid hematopoietic and related tissue (C96),0,N/A,1341
Male,2021 **,Other and unspecified malignant neoplasms of lymphoid hematopoietic and related tissue (C96),0,N/A,1344
Male,Total,Other and unspecified malignant neoplasms of lymphoid hematopoietic and related tissue (C96),0,N/A,1347
Unknown,2020 **,Other and unspecified malignant neoplasms of lymphoid hematopoietic and related tissue (C96),0,N/A,1350
Unknown,2021 **,Other and unspecified malignant neoplasms of lymphoid hematopoietic and related tissue (C96),0,N/A,1353
Unknown,Total,Other and unspecified malignant neoplasms of lymphoid hematopoietic and related tissue (C96),0,N/A,1356
Total,2020 **,Other and unspecified malignant neoplasms of lymphoid hematopoietic and related tissue (C96),1,N/A,1359
Total,2021 **,Other and unspecified malignant neoplasms of lymphoid hematopoietic and related tissue (C96),0,N/A,1362
Total,Total,Other and unspecified malignant neoplasms of lymphoid hematopoietic and related tissue (C96),1,N/A,1365
Female,2020 **,All other and unspecified malignant neoplasms (C17C23-C24C26-C31C37-C41C44-C49C51-C52C57-C60C62-C63C66C68-C69C73-C80C97),1330,15.5,1368
Female,2021 **,All other and unspecified malignant neoplasms (C17C23-C24C26-C31C37-C41C44-C49C51-C52C57-C60C62-C63C66C68-C69C73-C80C97),3,N/A,1371
Female,Total,All other and unspecified malignant neoplasms (C17C23-C24C26-C31C37-C41C44-C49C51-C52C57-C60C62-C63C66C68-C69C73-C80C97),1333,7.8,1374
Male,2020 **,All other and unspecified malignant neoplasms (C17C23-C24C26-C31C37-C41C44-C49C51-C52C57-C60C62-C63C66C68-C69C73-C80C97),1467,22.1,1377
Male,2021 **,All other and unspecified malignant neoplasms (C17C23-C24C26-C31C37-C41C44-C49C51-C52C57-C60C62-C63C66C68-C69C73-C80C97),5,N/A,1380
Male,Total,All other and unspecified malignant neoplasms (C17C23-C24C26-C31C37-C41C44-C49C51-C52C57-C60C62-C63C66C68-C69C73-C80C97),1472,11.1,1383
Unknown,2020 **,All other and unspecified malignant neoplasms (C17C23-C24C26-C31C37-C41C44-C49C51-C52C57-C60C62-C63C66C68-C69C73-C80C97),0,N/A,1386
Unknown,2021 **,All other and unspecified malignant neoplasms (C17C23-C24C26-C31C37-C41C44-C49C51-C52C57-C60C62-C63C66C68-C69C73-C80C97),0,N/A,1389
Unknown,Total,All other and unspecified malignant neoplasms (C17C23-C24C26-C31C37-C41C44-C49C51-C52C57-C60C62-C63C66C68-C69C73-C80C97),0,N/A,1392
Total,2020 **,All other and unspecified malignant neoplasms (C17C23-C24C26-C31C37-C41C44-C49C51-C52C57-C60C62-C63C66C68-C69C73-C80C97),2797,18.3,1395
Total,2021 **,All other and unspecified malignant neoplasms (C17C23-C24C26-C31C37-C41C44-C49C51-C52C57-C60C62-C63C66C68-C69C73-C80C97),8,N/A,1398
Total,Total,All other and unspecified malignant neoplasms (C17C23-C24C26-C31C37-C41C44-C49C51-C52C57-C60C62-C63C66C68-C69C73-C80C97),2805,9.2,1401
Female,2020 **,In situ neoplasms benign neoplasms and neoplasms of uncertain or unknown behavior (D00-D48),308,3.4,1404
Female,2021 **,In situ neoplasms benign neoplasms and neoplasms of uncertain or unknown behavior (D00-D48),0,N/A,1407
Female,Total,In situ neoplasms benign neoplasms and neoplasms of uncertain or unknown behavior (D00-D48),308,1.7,1410
Male,2020 **,In situ neoplasms benign neoplasms and neoplasms of uncertain or unknown behavior (D00-D48),310,4.9,1413
Male,2021 **,In situ neoplasms benign neoplasms and neoplasms of uncertain or unknown behavior (D00-D48),1,N/A,1416
Male,Total,In situ neoplasms benign neoplasms and neoplasms of uncertain or unknown behavior (D00-D48),311,2.4,1419
Unknown,2020 **,In situ neoplasms benign neoplasms and neoplasms of uncertain or unknown behavior (D00-D48),0,N/A,1422
Unknown,2021 **,In situ neoplasms benign neoplasms and neoplasms of uncertain or unknown behavior (D00-D48),0,N/A,1425
Unknown,Total,In situ neoplasms benign neoplasms and neoplasms of uncertain or unknown behavior (D00-D48),0,N/A,1428
Total,2020 **,In situ neoplasms benign neoplasms and neoplasms of uncertain or unknown behavior (D00-D48),618,4.0,1431
Total,2021 **,In situ neoplasms benign neoplasms and neoplasms of uncertain or unknown behavior (D00-D48),1,N/A,1434
Total,Total,In situ neoplasms benign neoplasms and neoplasms of uncertain or unknown behavior (D00-D48),619,2.0,1437
Female,2020 **,Anemias (D50-D64),107,1.2,1440
Female,2021 **,Anemias (D50-D64),1,N/A,1443
Female,Total,Anemias (D50-D64),108,0.6,1446
Male,2020 **,Anemias (D50-D64),88,1.4,1449
Male,2021 **,Anemias (D50-D64),0,N/A,1452
Male,Total,Anemias (D50-D64),88,0.7,1455
Unknown,2020 **,Anemias (D50-D64),0,N/A,1458
Unknown,2021 **,Anemias (D50-D64),0,N/A,1461
Unknown,Total,Anemias (D50-D64),0,N/A,1464
Total,2020 **,Anemias (D50-D64),195,1.3,1467
Total,2021 **,Anemias (D50-D64),1,N/A,1470
Total,Total,Anemias (D50-D64),196,0.7,1473
Female,2020 **,Diabetes mellitus (E10-E14),1740,20.1,1476
Female,2021 **,Diabetes mellitus (E10-E14),0,N/A,1479
Female,Total,Diabetes mellitus (E10-E14),1740,10.0,1482
Male,2020 **,Diabetes mellitus (E10-E14),2161,32.1,1485
Male,2021 **,Diabetes mellitus (E10-E14),3,N/A,1488
Male,Total,Diabetes mellitus (E10-E14),2164,16.1,1491
Unknown,2020 **,Diabetes mellitus (E10-E14),0,N/A,1494
Unknown,2021 **,Diabetes mellitus (E10-E14),0,N/A,1497
Unknown,Total,Diabetes mellitus (E10-E14),0,N/A,1500
Total,2020 **,Diabetes mellitus (E10-E14),3901,25.4,1503
Total,2021 **,Diabetes mellitus (E10-E14),3,N/A,1506
Total,Total,Diabetes mellitus (E10-E14),3904,12.7,1509
Female,2020 **,Malnutrition (E40-E46),365,3.7,1512
Female,2021 **,Malnutrition (E40-E46),0,N/A,1515
Female,Total,Malnutrition (E40-E46),365,1.9,1518
Male,2020 **,Malnutrition (E40-E46),196,3.2,1521
Male,2021 **,Malnutrition (E40-E46),1,N/A,1524
Male,Total,Malnutrition (E40-E46),197,1.6,1527
Unknown,2020 **,Malnutrition (E40-E46),0,N/A,1530
Unknown,2021 **,Malnutrition (E40-E46),0,N/A,1533
Unknown,Total,Malnutrition (E40-E46),0,N/A,1536
Total,2020 **,Malnutrition (E40-E46),561,3.5,1539
Total,2021 **,Malnutrition (E40-E46),1,N/A,1542
Total,Total,Malnutrition (E40-E46),562,1.8,1545
Female,2020 **,Other nutritional deficiencies (E50-E64),5,N/A,1548
Female,2021 **,Other nutritional deficiencies (E50-E64),0,N/A,1551
Female,Total,Other nutritional deficiencies (E50-E64),5,N/A,1554
Male,2020 **,Other nutritional deficiencies (E50-E64),3,N/A,1557
Male,2021 **,Other nutritional deficiencies (E50-E64),0,N/A,1560
Male,Total,Other nutritional deficiencies (E50-E64),3,N/A,1563
Unknown,2020 **,Other nutritional deficiencies (E50-E64),0,N/A,1566
Unknown,2021 **,Other nutritional deficiencies (E50-E64),0,N/A,1569
Unknown,Total,Other nutritional deficiencies (E50-E64),0,N/A,1572
Total,2020 **,Other nutritional deficiencies (E50-E64),8,N/A,1575
Total,2021 **,Other nutritional deficiencies (E50-E64),0,N/A,1578
Total,Total,Other nutritional deficiencies (E50-E64),8,N/A,1581
Female,2020 **,Meningitis (G00G03),6,N/A,1584
Female,2021 **,Meningitis (G00G03),0,N/A,1587
Female,Total,Meningitis (G00G03),6,N/A,1590
Male,2020 **,Meningitis (G00G03),7,N/A,1593
Male,2021 **,Meningitis (G00G03),0,N/A,1596
Male,Total,Meningitis (G00G03),7,N/A,1599
Unknown,2020 **,Meningitis (G00G03),0,N/A,1602
Unknown,2021 **,Meningitis (G00G03),0,N/A,1605
Unknown,Total,Meningitis (G00G03),0,N/A,1608
Total,2020 **,Meningitis (G00G03),13,0.1,1611
Total,2021 **,Meningitis (G00G03),0,N/A,1614
Total,Total,Meningitis (G00G03),13,0.0,1617
Female,2020 **,Parkinson's disease (G20-G21),630,7.0,1620
Female,2021 **,Parkinson's disease (G20-G21),1,N/A,1623
Female,Total,Parkinson's disease (G20-G21),631,3.5,1626
Male,2020 **,Parkinson's disease (G20-G21),896,14.7,1629
Male,2021 **,Parkinson's disease (G20-G21),5,N/A,1632
Male,Total,Parkinson's disease (G20-G21),901,7.4,1635
Unknown,2020 **,Parkinson's disease (G20-G21),0,N/A,1638
Unknown,2021 **,Parkinson's disease (G20-G21),0,N/A,1641
Unknown,Total,Parkinson's disease (G20-G21),0,N/A,1644
Total,2020 **,Parkinson's disease (G20-G21),1526,10.0,1647
Total,2021 **,Parkinson's disease (G20-G21),6,N/A,1650
Total,Total,Parkinson's disease (G20-G21),1532,5.0,1653
Female,2020 **,Alzheimer's disease (G30),3797,39.1,1656
Female,2021 **,Alzheimer's disease (G30),8,N/A,1659
Female,Total,Alzheimer's disease (G30),3805,19.6,1662
Male,2020 **,Alzheimer's disease (G30),1625,27.6,1665
Male,2021 **,Alzheimer's disease (G30),2,N/A,1668
Male,Total,Alzheimer's disease (G30),1627,13.8,1671
Unknown,2020 **,Alzheimer's disease (G30),0,N/A,1674
Unknown,2021 **,Alzheimer's disease (G30),0,N/A,1677
Unknown,Total,Alzheimer's disease (G30),0,N/A,1680
Total,2020 **,Alzheimer's disease (G30),5422,34.7,1683
Total,2021 **,Alzheimer's disease (G30),10,0.1,1686
Total,Total,Alzheimer's disease (G30),5432,17.4,1689
Female,2020 **,Acute rheumatic fever and chronic rheumatic heart diseases (I00-I09),117,1.3,1692
Female,2021 **,Acute rheumatic fever and chronic rheumatic heart diseases (I00-I09),0,N/A,1695
Female,Total,Acute rheumatic fever and chronic rheumatic heart diseases (I00-I09),117,0.7,1698
Male,2020 **,Acute rheumatic fever and chronic rheumatic heart diseases (I00-I09),50,0.8,1701
Male,2021 **,Acute rheumatic fever and chronic rheumatic heart diseases (I00-I09),0,N/A,1704
Male,Total,Acute rheumatic fever and chronic rheumatic heart diseases (I00-I09),50,0.4,1707
Unknown,2020 **,Acute rheumatic fever and chronic rheumatic heart diseases (I00-I09),0,N/A,1710
Unknown,2021 **,Acute rheumatic fever and chronic rheumatic heart diseases (I00-I09),0,N/A,1713
Unknown,Total,Acute rheumatic fever and chronic rheumatic heart diseases (I00-I09),0,N/A,1716
Total,2020 **,Acute rheumatic fever and chronic rheumatic heart diseases (I00-I09),167,1.1,1719
Total,2021 **,Acute rheumatic fever and chronic rheumatic heart diseases (I00-I09),0,N/A,1722
Total,Total,Acute rheumatic fever and chronic rheumatic heart diseases (I00-I09),167,0.5,1725
Female,2020 **,Hypertensive heart disease (I11),1037,11.4,1728
Female,2021 **,Hypertensive heart disease (I11),3,N/A,1731
Female,Total,Hypertensive heart disease (I11),1040,5.7,1734
Male,2020 **,Hypertensive heart disease (I11),977,14.9,1737
Male,2021 **,Hypertensive heart disease (I11),1,N/A,1740
Male,Total,Hypertensive heart disease (I11),978,7.5,1743
Unknown,2020 **,Hypertensive heart disease (I11),0,N/A,1746
Unknown,2021 **,Hypertensive heart disease (I11),0,N/A,1749
Unknown,Total,Hypertensive heart disease (I11),0,N/A,1752
Total,2020 **,Hypertensive heart disease (I11),2014,13.3,1755
Total,2021 **,Hypertensive heart disease (I11),4,N/A,1758
Total,Total,Hypertensive heart disease (I11),2018,6.6,1761
Female,2020 **,Hypertensive heart and renal disease (I13),221,2.3,1764
Female,2021 **,Hypertensive heart and renal disease (I13),0,N/A,1767
Female,Total,Hypertensive heart and renal disease (I13),221,1.2,1770
Male,2020 **,Hypertensive heart and renal disease (I13),187,3.0,1773
Male,2021 **,Hypertensive heart and renal disease (I13),2,N/A,1776
Male,Total,Hypertensive heart and renal disease (I13),189,1.5,1779
Unknown,2020 **,Hypertensive heart and renal disease (I13),0,N/A,1782
Unknown,2021 **,Hypertensive heart and renal disease (I13),0,N/A,1785
Unknown,Total,Hypertensive heart and renal disease (I13),0,N/A,1788
Total,2020 **,Hypertensive heart and renal disease (I13),408,2.6,1791
Total,2021 **,Hypertensive heart and renal disease (I13),2,N/A,1794
Total,Total,Hypertensive heart and renal disease (I13),410,1.3,1797
Female,2020 **,Acute myocardial infarction (I21-I22),1644,18.4,1800
Female,2021 **,Acute myocardial infarction (I21-I22),2,N/A,1803
Female,Total,Acute myocardial infarction (I21-I22),1646,9.2,1806
Male,2020 **,Acute myocardial infarction (I21-I22),2403,35.7,1809
Male,2021 **,Acute myocardial infarction (I21-I22),4,N/A,1812
Male,Total,Acute myocardial infarction (I21-I22),2407,17.9,1815
Unknown,2020 **,Acute myocardial infarction (I21-I22),0,N/A,1818
Unknown,2021 **,Acute myocardial infarction (I21-I22),0,N/A,1821
Unknown,Total,Acute myocardial infarction (I21-I22),0,N/A,1824
Total,2020 **,Acute myocardial infarction (I21-I22),4047,26.2,1827
Total,2021 **,Acute myocardial infarction (I21-I22),6,N/A,1830
Total,Total,Acute myocardial infarction (I21-I22),4053,13.1,1833
Female,2020 **,Other acute ischemic heart diseases (I24),86,1.0,1836
Female,2021 **,Other acute ischemic heart diseases (I24),0,N/A,1839
Female,Total,Other acute ischemic heart diseases (I24),86,0.5,1842
Male,2020 **,Other acute ischemic heart diseases (I24),109,1.6,1845
Male,2021 **,Other acute ischemic heart diseases (I24),1,N/A,1848
Male,Total,Other acute ischemic heart diseases (I24),110,0.8,1851
Unknown,2020 **,Other acute ischemic heart diseases (I24),0,N/A,1854
Unknown,2021 **,Other acute ischemic heart diseases (I24),0,N/A,1857
Unknown,Total,Other acute ischemic heart diseases (I24),0,N/A,1860
Total,2020 **,Other acute ischemic heart diseases (I24),195,1.3,1863
Total,2021 **,Other acute ischemic heart diseases (I24),1,N/A,1866
Total,Total,Other acute ischemic heart diseases (I24),196,0.6,1869
Female,2020 **,Atherosclerotic cardiovascular disease so described (I25.0),879,9.9,1872
Female,2021 **,Atherosclerotic cardiovascular disease so described (I25.0),3,N/A,1875
Female,Total,Atherosclerotic cardiovascular disease so described (I25.0),882,5.0,1878
Male,2020 **,Atherosclerotic cardiovascular disease so described (I25.0),1640,23.9,1881
Male,2021 **,Atherosclerotic cardiovascular disease so described (I25.0),3,N/A,1884
Male,Total,Atherosclerotic cardiovascular disease so described (I25.0),1643,12.0,1887
Unknown,2020 **,Atherosclerotic cardiovascular disease so described (I25.0),0,N/A,1890
Unknown,2021 **,Atherosclerotic cardiovascular disease so described (I25.0),0,N/A,1893
Unknown,Total,Atherosclerotic cardiovascular disease so described (I25.0),0,N/A,1896
Total,2020 **,Atherosclerotic cardiovascular disease so described (I25.0),2519,16.3,1899
Total,2021 **,Atherosclerotic cardiovascular disease so described (I25.0),6,N/A,1902
Total,Total,Atherosclerotic cardiovascular disease so described (I25.0),2525,8.2,1905
Female,2020 **,All other forms of chronic ischemic heart disease (I20I25.1-I25.9),3307,35.4,1908
Female,2021 **,All other forms of chronic ischemic heart disease (I20I25.1-I25.9),6,N/A,1911
Female,Total,All other forms of chronic ischemic heart disease (I20I25.1-I25.9),3313,17.7,1914
Male,2020 **,All other forms of chronic ischemic heart disease (I20I25.1-I25.9),4458,69.3,1917
Male,2021 **,All other forms of chronic ischemic heart disease (I20I25.1-I25.9),4,N/A,1920
Male,Total,All other forms of chronic ischemic heart disease (I20I25.1-I25.9),4462,34.7,1923
Unknown,2020 **,All other forms of chronic ischemic heart disease (I20I25.1-I25.9),0,N/A,1926
Unknown,2021 **,All other forms of chronic ischemic heart disease (I20I25.1-I25.9),0,N/A,1929
Unknown,Total,All other forms of chronic ischemic heart disease (I20I25.1-I25.9),0,N/A,1932
Total,2020 **,All other forms of chronic ischemic heart disease (I20I25.1-I25.9),7765,49.7,1935
Total,2021 **,All other forms of chronic ischemic heart disease (I20I25.1-I25.9),10,0.1,1938
Total,Total,All other forms of chronic ischemic heart disease (I20I25.1-I25.9),7775,24.9,1941
Female,2020 **,Acute and subacute endocarditis (I33),31,0.5,1944
Female,2021 **,Acute and subacute endocarditis (I33),0,N/A,1947
Female,Total,Acute and subacute endocarditis (I33),31,0.2,1950
Male,2020 **,Acute and subacute endocarditis (I33),51,0.8,1953
Male,2021 **,Acute and subacute endocarditis (I33),0,N/A,1956
Male,Total,Acute and subacute endocarditis (I33),51,0.4,1959
Unknown,2020 **,Acute and subacute endocarditis (I33),0,N/A,1962
Unknown,2021 **,Acute and subacute endocarditis (I33),0,N/A,1965
Unknown,Total,Acute and subacute endocarditis (I33),0,N/A,1968
Total,2020 **,Acute and subacute endocarditis (I33),82,0.6,1971
Total,2021 **,Acute and subacute endocarditis (I33),0,N/A,1974
Total,Total,Acute and subacute endocarditis (I33),82,0.3,1977
Female,2020 **,Diseases of pericardium and acute myocarditis (I30-I31I40),18,0.2,1980
Female,2021 **,Diseases of pericardium and acute myocarditis (I30-I31I40),0,N/A,1983
Female,Total,Diseases of pericardium and acute myocarditis (I30-I31I40),18,0.1,1986
Male,2020 **,Diseases of pericardium and acute myocarditis (I30-I31I40),22,0.4,1989
Male,2021 **,Diseases of pericardium and acute myocarditis (I30-I31I40),0,N/A,1992
Male,Total,Diseases of pericardium and acute myocarditis (I30-I31I40),22,0.2,1995
Unknown,2020 **,Diseases of pericardium and acute myocarditis (I30-I31I40),0,N/A,1998
Unknown,2021 **,Diseases of pericardium and acute myocarditis (I30-I31I40),0,N/A,2001
Unknown,Total,Diseases of pericardium and acute myocarditis (I30-I31I40),0,N/A,2004
Total,2020 **,Diseases of pericardium and acute myocarditis (I30-I31I40),40,0.3,2007
Total,2021 **,Diseases of pericardium and acute myocarditis (I30-I31I40),0,N/A,2010
Total,Total,Diseases of pericardium and acute myocarditis (I30-I31I40),40,0.1,2013
Female,2020 **,Heart failure (I50),2009,21.1,2016
Female,2021 **,Heart failure (I50),4,N/A,2019
Female,Total,Heart failure (I50),2013,10.6,2022
Male,2020 **,Heart failure (I50),1710,27.6,2025
Male,2021 **,Heart failure (I50),3,N/A,2028
Male,Total,Heart failure (I50),1713,13.8,2031
Unknown,2020 **,Heart failure (I50),0,N/A,2034
Unknown,2021 **,Heart failure (I50),0,N/A,2037
Unknown,Total,Heart failure (I50),0,N/A,2040
Total,2020 **,Heart failure (I50),3719,23.8,2043
Total,2021 **,Heart failure (I50),7,N/A,2046
Total,Total,Heart failure (I50),3726,11.9,2049
Female,2020 **,All other forms of heart disease (I26-I28I34-I38I42-I49I51),3431,38.6,2052
Female,2021 **,All other forms of heart disease (I26-I28I34-I38I42-I49I51),2,N/A,2055
Female,Total,All other forms of heart disease (I26-I28I34-I38I42-I49I51),3433,19.3,2058
Male,2020 **,All other forms of heart disease (I26-I28I34-I38I42-I49I51),3244,50.2,2061
Male,2021 **,All other forms of heart disease (I26-I28I34-I38I42-I49I51),2,N/A,2064
Male,Total,All other forms of heart disease (I26-I28I34-I38I42-I49I51),3246,25.1,2067
Unknown,2020 **,All other forms of heart disease (I26-I28I34-I38I42-I49I51),0,N/A,2070
Unknown,2021 **,All other forms of heart disease (I26-I28I34-I38I42-I49I51),0,N/A,2073
Unknown,Total,All other forms of heart disease (I26-I28I34-I38I42-I49I51),0,N/A,2076
Total,2020 **,All other forms of heart disease (I26-I28I34-I38I42-I49I51),6675,43.8,2079
Total,2021 **,All other forms of heart disease (I26-I28I34-I38I42-I49I51),4,N/A,2082
Total,Total,All other forms of heart disease (I26-I28I34-I38I42-I49I51),6679,21.9,2085
Female,2020 **,Essential (primary) hypertension and hypertensive renal disease (I10I12I15),804,8.7,2088
Female,2021 **,Essential (primary) hypertension and hypertensive renal disease (I10I12I15),3,N/A,2091
Female,Total,Essential (primary) hypertension and hypertensive renal disease (I10I12I15),807,4.4,2094
Male,2020 **,Essential (primary) hypertension and hypertensive renal disease (I10I12I15),626,9.6,2097
Male,2021 **,Essential (primary) hypertension and hypertensive renal disease (I10I12I15),1,N/A,2100
Male,Total,Essential (primary) hypertension and hypertensive renal disease (I10I12I15),627,4.8,2103
Unknown,2020 **,Essential (primary) hypertension and hypertensive renal disease (I10I12I15),0,N/A,2106
Unknown,2021 **,Essential (primary) hypertension and hypertensive renal disease (I10I12I15),0,N/A,2109
Unknown,Total,Essential (primary) hypertension and hypertensive renal disease (I10I12I15),0,N/A,2112
Total,2020 **,Essential (primary) hypertension and hypertensive renal disease (I10I12I15),1430,9.3,2115
Total,2021 **,Essential (primary) hypertension and hypertensive renal disease (I10I12I15),4,N/A,2118
Total,Total,Essential (primary) hypertension and hypertensive renal disease (I10I12I15),1434,4.6,2121
Female,2020 **,Cerebrovascular diseases (I60-I69),3716,40.1,2124
Female,2021 **,Cerebrovascular diseases (I60-I69),12,0.1,2127
Female,Total,Cerebrovascular diseases (I60-I69),3728,20.1,2130
Male,2020 **,Cerebrovascular diseases (I60-I69),2704,42.8,2133
Male,2021 **,Cerebrovascular diseases (I60-I69),4,N/A,2136
Male,Total,Cerebrovascular diseases (I60-I69),2708,21.4,2139
Unknown,2020 **,Cerebrovascular diseases (I60-I69),0,N/A,2142
Unknown,2021 **,Cerebrovascular diseases (I60-I69),0,N/A,2145
Unknown,Total,Cerebrovascular diseases (I60-I69),0,N/A,2148
Total,2020 **,Cerebrovascular diseases (I60-I69),6420,41.5,2151
Total,2021 **,Cerebrovascular diseases (I60-I69),16,0.1,2154
Total,Total,Cerebrovascular diseases (I60-I69),6436,20.8,2157
Female,2020 **,Atherosclerosis (I70),101,1.0,2160
Female,2021 **,Atherosclerosis (I70),0,N/A,2163
Female,Total,Atherosclerosis (I70),101,0.5,2166
Male,2020 **,Atherosclerosis (I70),83,1.3,2169
Male,2021 **,Atherosclerosis (I70),0,N/A,2172
Male,Total,Atherosclerosis (I70),83,0.7,2175
Unknown,2020 **,Atherosclerosis (I70),0,N/A,2178
Unknown,2021 **,Atherosclerosis (I70),0,N/A,2181
Unknown,Total,Atherosclerosis (I70),0,N/A,2184
Total,2020 **,Atherosclerosis (I70),184,1.2,2187
Total,2021 **,Atherosclerosis (I70),0,N/A,2190
Total,Total,Atherosclerosis (I70),184,0.6,2193
Female,2020 **,Aortic aneurysm and dissection (I71),164,1.9,2196
Female,2021 **,Aortic aneurysm and dissection (I71),0,N/A,2199
Female,Total,Aortic aneurysm and dissection (I71),164,0.9,2202
Male,2020 **,Aortic aneurysm and dissection (I71),231,3.6,2205
Male,2021 **,Aortic aneurysm and dissection (I71),1,N/A,2208
Male,Total,Aortic aneurysm and dissection (I71),232,1.8,2211
Unknown,2020 **,Aortic aneurysm and dissection (I71),0,N/A,2214
Unknown,2021 **,Aortic aneurysm and dissection (I71),0,N/A,2217
Unknown,Total,Aortic aneurysm and dissection (I71),0,N/A,2220
Total,2020 **,Aortic aneurysm and dissection (I71),395,2.6,2223
Total,2021 **,Aortic aneurysm and dissection (I71),1,N/A,2226
Total,Total,Aortic aneurysm and dissection (I71),396,1.3,2229
Female,2020 **,Other diseases of arteries arterioles and capillaries (I72-I78),209,2.3,2232
Female,2021 **,Other diseases of arteries arterioles and capillaries (I72-I78),1,N/A,2235
Female,Total,Other diseases of arteries arterioles and capillaries (I72-I78),210,1.2,2238
Male,2020 **,Other diseases of arteries arterioles and capillaries (I72-I78),232,3.5,2241
Male,2021 **,Other diseases of arteries arterioles and capillaries (I72-I78),1,N/A,2244
Male,Total,Other diseases of arteries arterioles and capillaries (I72-I78),233,1.8,2247
Unknown,2020 **,Other diseases of arteries arterioles and capillaries (I72-I78),0,N/A,2250
Unknown,2021 **,Other diseases of arteries arterioles and capillaries (I72-I78),0,N/A,2253
Unknown,Total,Other diseases of arteries arterioles and capillaries (I72-I78),0,N/A,2256
Total,2020 **,Other diseases of arteries arterioles and capillaries (I72-I78),441,2.8,2259
Total,2021 **,Other diseases of arteries arterioles and capillaries (I72-I78),2,N/A,2262
Total,Total,Other diseases of arteries arterioles and capillaries (I72-I78),443,1.4,2265
Female,2020 **,Other disorders of circulatory system (I80-I99),63,0.9,2268
Female,2021 **,Other disorders of circulatory system (I80-I99),0,N/A,2271
Female,Total,Other disorders of circulatory system (I80-I99),63,0.4,2274
Male,2020 **,Other disorders of circulatory system (I80-I99),91,1.5,2277
Male,2021 **,Other disorders of circulatory system (I80-I99),0,N/A,2280
Male,Total,Other disorders of circulatory system (I80-I99),91,0.7,2283
Unknown,2020 **,Other disorders of circulatory system (I80-I99),0,N/A,2286
Unknown,2021 **,Other disorders of circulatory system (I80-I99),0,N/A,2289
Unknown,Total,Other disorders of circulatory system (I80-I99),0,N/A,2292
Total,2020 **,Other disorders of circulatory system (I80-I99),154,1.1,2295
Total,2021 **,Other disorders of circulatory system (I80-I99),0,N/A,2298
Total,Total,Other disorders of circulatory system (I80-I99),154,0.6,2301
Female,2020 **,Influenza (J09-J11),117,1.5,2304
Female,2021 **,Influenza (J09-J11),0,N/A,2307
Female,Total,Influenza (J09-J11),117,0.7,2310
Male,2020 **,Influenza (J09-J11),112,1.7,2313
Male,2021 **,Influenza (J09-J11),0,N/A,2316
Male,Total,Influenza (J09-J11),112,0.8,2319
Unknown,2020 **,Influenza (J09-J11),0,N/A,2322
Unknown,2021 **,Influenza (J09-J11),0,N/A,2325
Unknown,Total,Influenza (J09-J11),0,N/A,2328
Total,2020 **,Influenza (J09-J11),229,1.6,2331
Total,2021 **,Influenza (J09-J11),0,N/A,2334
Total,Total,Influenza (J09-J11),229,0.8,2337
Female,2020 **,Pneumonia (J12-J18),793,8.8,2340
Female,2021 **,Pneumonia (J12-J18),1,N/A,2343
Female,Total,Pneumonia (J12-J18),794,4.4,2346
Male,2020 **,Pneumonia (J12-J18),843,13.1,2349
Male,2021 **,Pneumonia (J12-J18),2,N/A,2352
Male,Total,Pneumonia (J12-J18),845,6.6,2355
Unknown,2020 **,Pneumonia (J12-J18),0,N/A,2358
Unknown,2021 **,Pneumonia (J12-J18),0,N/A,2361
Unknown,Total,Pneumonia (J12-J18),0,N/A,2364
Total,2020 **,Pneumonia (J12-J18),1636,10.7,2367
Total,2021 **,Pneumonia (J12-J18),3,N/A,2370
Total,Total,Pneumonia (J12-J18),1639,5.3,2373
Female,2020 **,Acute bronchitis and bronchiolitis (J20-J21),4,N/A,2376
Female,2021 **,Acute bronchitis and bronchiolitis (J20-J21),0,N/A,2379
Female,Total,Acute bronchitis and bronchiolitis (J20-J21),4,N/A,2382
Male,2020 **,Acute bronchitis and bronchiolitis (J20-J21),5,N/A,2385
Male,2021 **,Acute bronchitis and bronchiolitis (J20-J21),0,N/A,2388
Male,Total,Acute bronchitis and bronchiolitis (J20-J21),5,N/A,2391
Unknown,2020 **,Acute bronchitis and bronchiolitis (J20-J21),0,N/A,2394
Unknown,2021 **,Acute bronchitis and bronchiolitis (J20-J21),0,N/A,2397
Unknown,Total,Acute bronchitis and bronchiolitis (J20-J21),0,N/A,2400
Total,2020 **,Acute bronchitis and bronchiolitis (J20-J21),9,N/A,2403
Total,2021 **,Acute bronchitis and bronchiolitis (J20-J21),0,N/A,2406
Total,Total,Acute bronchitis and bronchiolitis (J20-J21),9,N/A,2409
Female,2020 **,Unspecified acute lower respiratory infection (J22U049U071),4260,46.6,2412
Female,2021 **,Unspecified acute lower respiratory infection (J22U049U071),8,N/A,2415
Female,Total,Unspecified acute lower respiratory infection (J22U049U071),4268,23.4,2418
Male,2020 **,Unspecified acute lower respiratory infection (J22U049U071),4696,73.4,2421
Male,2021 **,Unspecified acute lower respiratory infection (J22U049U071),10,0.1,2424
Male,Total,Unspecified acute lower respiratory infection (J22U049U071),4706,36.8,2427
Unknown,2020 **,Unspecified acute lower respiratory infection (J22U049U071),0,N/A,2430
Unknown,2021 **,Unspecified acute lower respiratory infection (J22U049U071),0,N/A,2433
Unknown,Total,Unspecified acute lower respiratory infection (J22U049U071),0,N/A,2436
Total,2020 **,Unspecified acute lower respiratory infection (J22U049U071),8956,58.0,2439
Total,2021 **,Unspecified acute lower respiratory infection (J22U049U071),18,0.1,2442
Total,Total,Unspecified acute lower respiratory infection (J22U049U071),8974,29.1,2445
Female,2020 **,Bronchitis chronic and unspecified (J40-J42),11,0.1,2448
Female,2021 **,Bronchitis chronic and unspecified (J40-J42),0,N/A,2451
Female,Total,Bronchitis chronic and unspecified (J40-J42),11,0.1,2454
Male,2020 **,Bronchitis chronic and unspecified (J40-J42),6,N/A,2457
Male,2021 **,Bronchitis chronic and unspecified (J40-J42),0,N/A,2460
Male,Total,Bronchitis chronic and unspecified (J40-J42),6,N/A,2463
Unknown,2020 **,Bronchitis chronic and unspecified (J40-J42),0,N/A,2466
Unknown,2021 **,Bronchitis chronic and unspecified (J40-J42),0,N/A,2469
Unknown,Total,Bronchitis chronic and unspecified (J40-J42),0,N/A,2472
Total,2020 **,Bronchitis chronic and unspecified (J40-J42),17,0.1,2475
Total,2021 **,Bronchitis chronic and unspecified (J40-J42),0,N/A,2478
Total,Total,Bronchitis chronic and unspecified (J40-J42),17,0.1,2481
Female,2020 **,Emphysema (J43),173,1.9,2484
Female,2021 **,Emphysema (J43),0,N/A,2487
Female,Total,Emphysema (J43),173,0.9,2490
Male,2020 **,Emphysema (J43),195,2.9,2493
Male,2021 **,Emphysema (J43),0,N/A,2496
Male,Total,Emphysema (J43),195,1.4,2499
Unknown,2020 **,Emphysema (J43),0,N/A,2502
Unknown,2021 **,Emphysema (J43),0,N/A,2505
Unknown,Total,Emphysema (J43),0,N/A,2508
Total,2020 **,Emphysema (J43),368,2.3,2511
Total,2021 **,Emphysema (J43),0,N/A,2514
Total,Total,Emphysema (J43),368,1.2,2517
Female,2020 **,Asthma (J45-J46),65,0.9,2520
Female,2021 **,Asthma (J45-J46),0,N/A,2523
Female,Total,Asthma (J45-J46),65,0.5,2526
Male,2020 **,Asthma (J45-J46),57,0.9,2529
Male,2021 **,Asthma (J45-J46),0,N/A,2532
Male,Total,Asthma (J45-J46),57,0.5,2535
Unknown,2020 **,Asthma (J45-J46),0,N/A,2538
Unknown,2021 **,Asthma (J45-J46),0,N/A,2541
Unknown,Total,Asthma (J45-J46),0,N/A,2544
Total,2020 **,Asthma (J45-J46),122,0.9,2547
Total,2021 **,Asthma (J45-J46),0,N/A,2550
Total,Total,Asthma (J45-J46),122,0.5,2553
Female,2020 **,Other chronic lower respiratory diseases (J44J47),3127,35.1,2556
Female,2021 **,Other chronic lower respiratory diseases (J44J47),4,N/A,2559
Female,Total,Other chronic lower respiratory diseases (J44J47),3131,17.6,2562
Male,2020 **,Other chronic lower respiratory diseases (J44J47),2817,42.0,2565
Male,2021 **,Other chronic lower respiratory diseases (J44J47),4,N/A,2568
Male,Total,Other chronic lower respiratory diseases (J44J47),2821,21.0,2571
Unknown,2020 **,Other chronic lower respiratory diseases (J44J47),0,N/A,2574
Unknown,2021 **,Other chronic lower respiratory diseases (J44J47),0,N/A,2577
Unknown,Total,Other chronic lower respiratory diseases (J44J47),0,N/A,2580
Total,2020 **,Other chronic lower respiratory diseases (J44J47),5944,37.9,2583
Total,2021 **,Other chronic lower respiratory diseases (J44J47),8,N/A,2586
Total,Total,Other chronic lower respiratory diseases (J44J47),5952,19.0,2589
Female,2020 **,Pneumoconioses and chemical effects (J60-J66J68),0,N/A,2592
Female,2021 **,Pneumoconioses and chemical effects (J60-J66J68),0,N/A,2595
Female,Total,Pneumoconioses and chemical effects (J60-J66J68),0,N/A,2598
Male,2020 **,Pneumoconioses and chemical effects (J60-J66J68),21,0.3,2601
Male,2021 **,Pneumoconioses and chemical effects (J60-J66J68),0,N/A,2604
Male,Total,Pneumoconioses and chemical effects (J60-J66J68),21,0.2,2607
Unknown,2020 **,Pneumoconioses and chemical effects (J60-J66J68),0,N/A,2610
Unknown,2021 **,Pneumoconioses and chemical effects (J60-J66J68),0,N/A,2613
Unknown,Total,Pneumoconioses and chemical effects (J60-J66J68),0,N/A,2616
Total,2020 **,Pneumoconioses and chemical effects (J60-J66J68),21,0.1,2619
Total,2021 **,Pneumoconioses and chemical effects (J60-J66J68),0,N/A,2622
Total,Total,Pneumoconioses and chemical effects (J60-J66J68),21,0.1,2625
Female,2020 **,Pneumonitis due to solids and liquids (J69),333,3.6,2628
Female,2021 **,Pneumonitis due to solids and liquids (J69),0,N/A,2631
Female,Total,Pneumonitis due to solids and liquids (J69),333,1.8,2634
Male,2020 **,Pneumonitis due to solids and liquids (J69),444,7.1,2637
Male,2021 **,Pneumonitis due to solids and liquids (J69),2,N/A,2640
Male,Total,Pneumonitis due to solids and liquids (J69),446,3.6,2643
Unknown,2020 **,Pneumonitis due to solids and liquids (J69),0,N/A,2646
Unknown,2021 **,Pneumonitis due to solids and liquids (J69),0,N/A,2649
Unknown,Total,Pneumonitis due to solids and liquids (J69),0,N/A,2652
Total,2020 **,Pneumonitis due to solids and liquids (J69),777,5.0,2655
Total,2021 **,Pneumonitis due to solids and liquids (J69),2,N/A,2658
Total,Total,Pneumonitis due to solids and liquids (J69),779,2.5,2661
Female,2020 **,Other diseases of respiratory system (J00-J06J30-J39J67J70-J98),971,11.1,2664
Female,2021 **,Other diseases of respiratory system (J00-J06J30-J39J67J70-J98),1,N/A,2667
Female,Total,Other diseases of respiratory system (J00-J06J30-J39J67J70-J98),972,5.5,2670
Male,2020 **,Other diseases of respiratory system (J00-J06J30-J39J67J70-J98),996,15.4,2673
Male,2021 **,Other diseases of respiratory system (J00-J06J30-J39J67J70-J98),0,N/A,2676
Male,Total,Other diseases of respiratory system (J00-J06J30-J39J67J70-J98),996,7.7,2679
Unknown,2020 **,Other diseases of respiratory system (J00-J06J30-J39J67J70-J98),0,N/A,2682
Unknown,2021 **,Other diseases of respiratory system (J00-J06J30-J39J67J70-J98),0,N/A,2685
Unknown,Total,Other diseases of respiratory system (J00-J06J30-J39J67J70-J98),0,N/A,2688
Total,2020 **,Other diseases of respiratory system (J00-J06J30-J39J67J70-J98),1967,12.9,2691
Total,2021 **,Other diseases of respiratory system (J00-J06J30-J39J67J70-J98),1,N/A,2694
Total,Total,Other diseases of respiratory system (J00-J06J30-J39J67J70-J98),1968,6.5,2697
Female,2020 **,Peptic ulcer (K25-K28),68,0.8,2700
Female,2021 **,Peptic ulcer (K25-K28),0,N/A,2703
Female,Total,Peptic ulcer (K25-K28),68,0.4,2706
Male,2020 **,Peptic ulcer (K25-K28),67,1.0,2709
Male,2021 **,Peptic ulcer (K25-K28),0,N/A,2712
Male,Total,Peptic ulcer (K25-K28),67,0.5,2715
Unknown,2020 **,Peptic ulcer (K25-K28),0,N/A,2718
Unknown,2021 **,Peptic ulcer (K25-K28),0,N/A,2721
Unknown,Total,Peptic ulcer (K25-K28),0,N/A,2724
Total,2020 **,Peptic ulcer (K25-K28),135,0.9,2727
Total,2021 **,Peptic ulcer (K25-K28),0,N/A,2730
Total,Total,Peptic ulcer (K25-K28),135,0.4,2733
Female,2020 **,Diseases of appendix (K35-K38),2,N/A,2736
Female,2021 **,Diseases of appendix (K35-K38),0,N/A,2739
Female,Total,Diseases of appendix (K35-K38),2,N/A,2742
Male,2020 **,Diseases of appendix (K35-K38),8,N/A,2745
Male,2021 **,Diseases of appendix (K35-K38),0,N/A,2748
Male,Total,Diseases of appendix (K35-K38),8,N/A,2751
Unknown,2020 **,Diseases of appendix (K35-K38),0,N/A,2754
Unknown,2021 **,Diseases of appendix (K35-K38),0,N/A,2757
Unknown,Total,Diseases of appendix (K35-K38),0,N/A,2760
Total,2020 **,Diseases of appendix (K35-K38),10,0.1,2763
Total,2021 **,Diseases of appendix (K35-K38),0,N/A,2766
Total,Total,Diseases of appendix (K35-K38),10,0.0,2769
Female,2020 **,Hernia (K40-K46),36,0.4,2772
Female,2021 **,Hernia (K40-K46),1,N/A,2775
Female,Total,Hernia (K40-K46),37,0.2,2778
Male,2020 **,Hernia (K40-K46),24,0.4,2781
Male,2021 **,Hernia (K40-K46),0,N/A,2784
Male,Total,Hernia (K40-K46),24,0.2,2787
Unknown,2020 **,Hernia (K40-K46),0,N/A,2790
Unknown,2021 **,Hernia (K40-K46),0,N/A,2793
Unknown,Total,Hernia (K40-K46),0,N/A,2796
Total,2020 **,Hernia (K40-K46),60,0.4,2799
Total,2021 **,Hernia (K40-K46),1,N/A,2802
Total,Total,Hernia (K40-K46),61,0.2,2805
Female,2020 **,Alcoholic liver disease (K70),260,3.8,2808
Female,2021 **,Alcoholic liver disease (K70),0,N/A,2811
Female,Total,Alcoholic liver disease (K70),260,1.9,2814
Male,2020 **,Alcoholic liver disease (K70),569,8.3,2817
Male,2021 **,Alcoholic liver disease (K70),0,N/A,2820
Male,Total,Alcoholic liver disease (K70),569,4.1,2823
Unknown,2020 **,Alcoholic liver disease (K70),0,N/A,2826
Unknown,2021 **,Alcoholic liver disease (K70),0,N/A,2829
Unknown,Total,Alcoholic liver disease (K70),0,N/A,2832
Total,2020 **,Alcoholic liver disease (K70),829,5.9,2835
Total,2021 **,Alcoholic liver disease (K70),0,N/A,2838
Total,Total,Alcoholic liver disease (K70),829,3.0,2841
Female,2020 **,Other chronic liver disease and cirrhosis (K73-K74),352,4.4,2844
Female,2021 **,Other chronic liver disease and cirrhosis (K73-K74),0,N/A,2847
Female,Total,Other chronic liver disease and cirrhosis (K73-K74),352,2.2,2850
Male,2020 **,Other chronic liver disease and cirrhosis (K73-K74),421,6.1,2853
Male,2021 **,Other chronic liver disease and cirrhosis (K73-K74),0,N/A,2856
Male,Total,Other chronic liver disease and cirrhosis (K73-K74),421,3.0,2859
Unknown,2020 **,Other chronic liver disease and cirrhosis (K73-K74),0,N/A,2862
Unknown,2021 **,Other chronic liver disease and cirrhosis (K73-K74),0,N/A,2865
Unknown,Total,Other chronic liver disease and cirrhosis (K73-K74),0,N/A,2868
Total,2020 **,Other chronic liver disease and cirrhosis (K73-K74),773,5.2,2871
Total,2021 **,Other chronic liver disease and cirrhosis (K73-K74),0,N/A,2874
Total,Total,Other chronic liver disease and cirrhosis (K73-K74),773,2.6,2877
Female,2020 **,Cholelithiasis and other disorders of gallbladder (K80-K82),75,0.8,2880
Female,2021 **,Cholelithiasis and other disorders of gallbladder (K80-K82),0,N/A,2883
Female,Total,Cholelithiasis and other disorders of gallbladder (K80-K82),75,0.4,2886
Male,2020 **,Cholelithiasis and other disorders of gallbladder (K80-K82),57,0.9,2889
Male,2021 **,Cholelithiasis and other disorders of gallbladder (K80-K82),0,N/A,2892
Male,Total,Cholelithiasis and other disorders of gallbladder (K80-K82),57,0.4,2895
Unknown,2020 **,Cholelithiasis and other disorders of gallbladder (K80-K82),0,N/A,2898
Unknown,2021 **,Cholelithiasis and other disorders of gallbladder (K80-K82),0,N/A,2901
Unknown,Total,Cholelithiasis and other disorders of gallbladder (K80-K82),0,N/A,2904
Total,2020 **,Cholelithiasis and other disorders of gallbladder (K80-K82),132,0.9,2907
Total,2021 **,Cholelithiasis and other disorders of gallbladder (K80-K82),0,N/A,2910
Total,Total,Cholelithiasis and other disorders of gallbladder (K80-K82),132,0.4,2913
Female,2020 **,Acute and rapidly progressive nephritic and nephrotic syndrome (N00-N01N04),10,0.1,2916
Female,2021 **,Acute and rapidly progressive nephritic and nephrotic syndrome (N00-N01N04),0,N/A,2919
Female,Total,Acute and rapidly progressive nephritic and nephrotic syndrome (N00-N01N04),10,0.1,2922
Male,2020 **,Acute and rapidly progressive nephritic and nephrotic syndrome (N00-N01N04),16,0.3,2925
Male,2021 **,Acute and rapidly progressive nephritic and nephrotic syndrome (N00-N01N04),0,N/A,2928
Male,Total,Acute and rapidly progressive nephritic and nephrotic syndrome (N00-N01N04),16,0.1,2931
Unknown,2020 **,Acute and rapidly progressive nephritic and nephrotic syndrome (N00-N01N04),0,N/A,2934
Unknown,2021 **,Acute and rapidly progressive nephritic and nephrotic syndrome (N00-N01N04),0,N/A,2937
Unknown,Total,Acute and rapidly progressive nephritic and nephrotic syndrome (N00-N01N04),0,N/A,2940
Total,2020 **,Acute and rapidly progressive nephritic and nephrotic syndrome (N00-N01N04),26,0.2,2943
Total,2021 **,Acute and rapidly progressive nephritic and nephrotic syndrome (N00-N01N04),0,N/A,2946
Total,Total,Acute and rapidly progressive nephritic and nephrotic syndrome (N00-N01N04),26,0.1,2949
Female,2020 **,Chronic glomerulonephritis nephritis and nephritis not specified as acute or chronicand renal sclerosis unspecified (N02-N03N05-N07N26),7,N/A,2952
Female,2021 **,Chronic glomerulonephritis nephritis and nephritis not specified as acute or chronicand renal sclerosis unspecified (N02-N03N05-N07N26),0,N/A,2955
Female,Total,Chronic glomerulonephritis nephritis and nephritis not specified as acute or chronicand renal sclerosis unspecified (N02-N03N05-N07N26),7,N/A,2958
Male,2020 **,Chronic glomerulonephritis nephritis and nephritis not specified as acute or chronicand renal sclerosis unspecified (N02-N03N05-N07N26),3,N/A,2961
Male,2021 **,Chronic glomerulonephritis nephritis and nephritis not specified as acute or chronicand renal sclerosis unspecified (N02-N03N05-N07N26),0,N/A,2964
Male,Total,Chronic glomerulonephritis nephritis and nephritis not specified as acute or chronicand renal sclerosis unspecified (N02-N03N05-N07N26),3,N/A,2967
Unknown,2020 **,Chronic glomerulonephritis nephritis and nephritis not specified as acute or chronicand renal sclerosis unspecified (N02-N03N05-N07N26),0,N/A,2970
Unknown,2021 **,Chronic glomerulonephritis nephritis and nephritis not specified as acute or chronicand renal sclerosis unspecified (N02-N03N05-N07N26),0,N/A,2973
Unknown,Total,Chronic glomerulonephritis nephritis and nephritis not specified as acute or chronicand renal sclerosis unspecified (N02-N03N05-N07N26),0,N/A,2976
Total,2020 **,Chronic glomerulonephritis nephritis and nephritis not specified as acute or chronicand renal sclerosis unspecified (N02-N03N05-N07N26),10,0.1,2979
Total,2021 **,Chronic glomerulonephritis nephritis and nephritis not specified as acute or chronicand renal sclerosis unspecified (N02-N03N05-N07N26),0,N/A,2982
Total,Total,Chronic glomerulonephritis nephritis and nephritis not specified as acute or chronicand renal sclerosis unspecified (N02-N03N05-N07N26),10,0.0,2985
Female,2020 **,Renal failure (N17-N19),996,11.1,2988
Female,2021 **,Renal failure (N17-N19),1,N/A,2991
Female,Total,Renal failure (N17-N19),997,5.6,2994
Male,2020 **,Renal failure (N17-N19),962,14.8,2997
Male,2021 **,Renal failure (N17-N19),3,N/A,3000
Male,Total,Renal failure (N17-N19),965,7.4,3003
Unknown,2020 **,Renal failure (N17-N19),0,N/A,3006
Unknown,2021 **,Renal failure (N17-N19),0,N/A,3009
Unknown,Total,Renal failure (N17-N19),0,N/A,3012
Total,2020 **,Renal failure (N17-N19),1958,12.7,3015
Total,2021 **,Renal failure (N17-N19),4,N/A,3018
Total,Total,Renal failure (N17-N19),1962,6.3,3021
Female,2020 **,Other disorders of kidney (N25N27),0,N/A,3024
Female,2021 **,Other disorders of kidney (N25N27),0,N/A,3027
Female,Total,Other disorders of kidney (N25N27),0,N/A,3030
Male,2020 **,Other disorders of kidney (N25N27),0,N/A,3033
Male,2021 **,Other disorders of kidney (N25N27),0,N/A,3036
Male,Total,Other disorders of kidney (N25N27),0,N/A,3039
Unknown,2020 **,Other disorders of kidney (N25N27),0,N/A,3042
Unknown,2021 **,Other disorders of kidney (N25N27),0,N/A,3045
Unknown,Total,Other disorders of kidney (N25N27),0,N/A,3048
Total,2020 **,Other disorders of kidney (N25N27),0,N/A,3051
Total,2021 **,Other disorders of kidney (N25N27),0,N/A,3054
Total,Total,Other disorders of kidney (N25N27),0,N/A,3057
Female,2020 **,Infections of kidney (N10-N12N13.6N15.1),21,0.3,3060
Female,2021 **,Infections of kidney (N10-N12N13.6N15.1),0,N/A,3063
Female,Total,Infections of kidney (N10-N12N13.6N15.1),21,0.1,3066
Male,2020 **,Infections of kidney (N10-N12N13.6N15.1),17,0.2,3069
Male,2021 **,Infections of kidney (N10-N12N13.6N15.1),0,N/A,3072
Male,Total,Infections of kidney (N10-N12N13.6N15.1),17,0.1,3075
Unknown,2020 **,Infections of kidney (N10-N12N13.6N15.1),0,N/A,3078
Unknown,2021 **,Infections of kidney (N10-N12N13.6N15.1),0,N/A,3081
Unknown,Total,Infections of kidney (N10-N12N13.6N15.1),0,N/A,3084
Total,2020 **,Infections of kidney (N10-N12N13.6N15.1),38,0.3,3087
Total,2021 **,Infections of kidney (N10-N12N13.6N15.1),0,N/A,3090
Total,Total,Infections of kidney (N10-N12N13.6N15.1),38,0.1,3093
Female,2020 **,Hyperplasia of prostate (N40),0,N/A,3096
Female,2021 **,Hyperplasia of prostate (N40),0,N/A,3099
Female,Total,Hyperplasia of prostate (N40),0,N/A,3102
Male,2020 **,Hyperplasia of prostate (N40),19,0.3,3105
Male,2021 **,Hyperplasia of prostate (N40),0,N/A,3108
Male,Total,Hyperplasia of prostate (N40),19,0.2,3111
Unknown,2020 **,Hyperplasia of prostate (N40),0,N/A,3114
Unknown,2021 **,Hyperplasia of prostate (N40),0,N/A,3117
Unknown,Total,Hyperplasia of prostate (N40),0,N/A,3120
Total,2020 **,Hyperplasia of prostate (N40),19,0.1,3123
Total,2021 **,Hyperplasia of prostate (N40),0,N/A,3126
Total,Total,Hyperplasia of prostate (N40),19,0.1,3129
Female,2020 **,Inflammatory diseases of female pelvic organs (N70-N76),8,N/A,3132
Female,2021 **,Inflammatory diseases of female pelvic organs (N70-N76),0,N/A,3135
Female,Total,Inflammatory diseases of female pelvic organs (N70-N76),8,N/A,3138
Male,2020 **,Inflammatory diseases of female pelvic organs (N70-N76),0,N/A,3141
Male,2021 **,Inflammatory diseases of female pelvic organs (N70-N76),0,N/A,3144
Male,Total,Inflammatory diseases of female pelvic organs (N70-N76),0,N/A,3147
Unknown,2020 **,Inflammatory diseases of female pelvic organs (N70-N76),0,N/A,3150
Unknown,2021 **,Inflammatory diseases of female pelvic organs (N70-N76),0,N/A,3153
Unknown,Total,Inflammatory diseases of female pelvic organs (N70-N76),0,N/A,3156
Total,2020 **,Inflammatory diseases of female pelvic organs (N70-N76),8,N/A,3159
Total,2021 **,Inflammatory diseases of female pelvic organs (N70-N76),0,N/A,3162
Total,Total,Inflammatory diseases of female pelvic organs (N70-N76),8,N/A,3165
Female,2020 **,Pregnancy with abortive outcome (O00-O07),0,N/A,3168
Female,2021 **,Pregnancy with abortive outcome (O00-O07),0,N/A,3171
Female,Total,Pregnancy with abortive outcome (O00-O07),0,N/A,3174
Male,2020 **,Pregnancy with abortive outcome (O00-O07),0,N/A,3177
Male,2021 **,Pregnancy with abortive outcome (O00-O07),0,N/A,3180
Male,Total,Pregnancy with abortive outcome (O00-O07),0,N/A,3183
Unknown,2020 **,Pregnancy with abortive outcome (O00-O07),0,N/A,3186
Unknown,2021 **,Pregnancy with abortive outcome (O00-O07),0,N/A,3189
Unknown,Total,Pregnancy with abortive outcome (O00-O07),0,N/A,3192
Total,2020 **,Pregnancy with abortive outcome (O00-O07),0,N/A,3195
Total,2021 **,Pregnancy with abortive outcome (O00-O07),0,N/A,3198
Total,Total,Pregnancy with abortive outcome (O00-O07),0,N/A,3201
Female,2020 **,Other complications of pregnancy childbirth and the puerperium (O10-O99),23,0.4,3204
Female,2021 **,Other complications of pregnancy childbirth and the puerperium (O10-O99),0,N/A,3207
Female,Total,Other complications of pregnancy childbirth and the puerperium (O10-O99),23,0.2,3210
Male,2020 **,Other complications of pregnancy childbirth and the puerperium (O10-O99),0,N/A,3213
Male,2021 **,Other complications of pregnancy childbirth and the puerperium (O10-O99),0,N/A,3216
Male,Total,Other complications of pregnancy childbirth and the puerperium (O10-O99),0,N/A,3219
Unknown,2020 **,Other complications of pregnancy childbirth and the puerperium (O10-O99),0,N/A,3222
Unknown,2021 **,Other complications of pregnancy childbirth and the puerperium (O10-O99),0,N/A,3225
Unknown,Total,Other complications of pregnancy childbirth and the puerperium (O10-O99),0,N/A,3228
Total,2020 **,Other complications of pregnancy childbirth and the puerperium (O10-O99),23,0.2,3231
Total,2021 **,Other complications of pregnancy childbirth and the puerperium (O10-O99),0,N/A,3234
Total,Total,Other complications of pregnancy childbirth and the puerperium (O10-O99),23,0.1,3237
Female,2020 **,Certain conditions originating in the perinatal period (P00-P96),162,3.4,3240
Female,2021 **,Certain conditions originating in the perinatal period (P00-P96),0,N/A,3243
Female,Total,Certain conditions originating in the perinatal period (P00-P96),162,1.7,3246
Male,2020 **,Certain conditions originating in the perinatal period (P00-P96),213,4.3,3249
Male,2021 **,Certain conditions originating in the perinatal period (P00-P96),0,N/A,3252
Male,Total,Certain conditions originating in the perinatal period (P00-P96),213,2.2,3255
Unknown,2020 **,Certain conditions originating in the perinatal period (P00-P96),1,N/A,3258
Unknown,2021 **,Certain conditions originating in the perinatal period (P00-P96),0,N/A,3261
Unknown,Total,Certain conditions originating in the perinatal period (P00-P96),1,N/A,3264
Total,2020 **,Certain conditions originating in the perinatal period (P00-P96),376,3.9,3267
Total,2021 **,Certain conditions originating in the perinatal period (P00-P96),0,N/A,3270
Total,Total,Certain conditions originating in the perinatal period (P00-P96),376,1.9,3273
Female,2020 **,Congenital malformations deformations and chromosomal abnormalities (Q00-Q99),185,3.2,3276
Female,2021 **,Congenital malformations deformations and chromosomal abnormalities (Q00-Q99),0,N/A,3279
Female,Total,Congenital malformations deformations and chromosomal abnormalities (Q00-Q99),185,1.6,3282
Male,2020 **,Congenital malformations deformations and chromosomal abnormalities (Q00-Q99),169,3.1,3285
Male,2021 **,Congenital malformations deformations and chromosomal abnormalities (Q00-Q99),0,N/A,3288
Male,Total,Congenital malformations deformations and chromosomal abnormalities (Q00-Q99),169,1.5,3291
Unknown,2020 **,Congenital malformations deformations and chromosomal abnormalities (Q00-Q99),0,N/A,3294
Unknown,2021 **,Congenital malformations deformations and chromosomal abnormalities (Q00-Q99),0,N/A,3297
Unknown,Total,Congenital malformations deformations and chromosomal abnormalities (Q00-Q99),0,N/A,3300
Total,2020 **,Congenital malformations deformations and chromosomal abnormalities (Q00-Q99),354,3.1,3303
Total,2021 **,Congenital malformations deformations and chromosomal abnormalities (Q00-Q99),0,N/A,3306
Total,Total,Congenital malformations deformations and chromosomal abnormalities (Q00-Q99),354,1.6,3309
Female,2020 **,Symptoms signs and abnormal clinical and laboratory findings not elsewhere classified (R00-R99),6494,76.8,3312
Female,2021 **,Symptoms signs and abnormal clinical and laboratory findings not elsewhere classified (R00-R99),637,7.0,3315
Female,Total,Symptoms signs and abnormal clinical and laboratory findings not elsewhere classified (R00-R99),7131,41.9,3318
Male,2020 **,Symptoms signs and abnormal clinical and laboratory findings not elsewhere classified (R00-R99),7089,112.6,3321
Male,2021 **,Symptoms signs and abnormal clinical and laboratory findings not elsewhere classified (R00-R99),686,10.7,3324
Male,Total,Symptoms signs and abnormal clinical and laboratory findings not elsewhere classified (R00-R99),7775,61.7,3327
Unknown,2020 **,Symptoms signs and abnormal clinical and laboratory findings not elsewhere classified (R00-R99),0,N/A,3330
Unknown,2021 **,Symptoms signs and abnormal clinical and laboratory findings not elsewhere classified (R00-R99),0,N/A,3333
Unknown,Total,Symptoms signs and abnormal clinical and laboratory findings not elsewhere classified (R00-R99),0,N/A,3336
Total,2020 **,Symptoms signs and abnormal clinical and laboratory findings not elsewhere classified (R00-R99),13583,93.5,3339
Total,2021 **,Symptoms signs and abnormal clinical and laboratory findings not elsewhere classified (R00-R99),1323,8.7,3342
Total,Total,Symptoms signs and abnormal clinical and laboratory findings not elsewhere classified (R00-R99),14906,51.1,3345
Female,2020 **,All other diseases (Residual) (D65-E07E15-E34E65-F99G04-G12G23-G25G31-H93K00-K22K29-K31K50-K66K71-K72K75-K76K83-M99N13.0-N13.5N13.7-N13.9N14N15.0N15.8-N15.9N20-N23N28-N39N41-N64N80-N98),8717,96.8,3348
Female,2021 **,All other diseases (Residual) (D65-E07E15-E34E65-F99G04-G12G23-G25G31-H93K00-K22K29-K31K50-K66K71-K72K75-K76K83-M99N13.0-N13.5N13.7-N13.9N14N15.0N15.8-N15.9N20-N23N28-N39N41-N64N80-N98),8,N/A,3351
Female,Total,All other diseases (Residual) (D65-E07E15-E34E65-F99G04-G12G23-G25G31-H93K00-K22K29-K31K50-K66K71-K72K75-K76K83-M99N13.0-N13.5N13.7-N13.9N14N15.0N15.8-N15.9N20-N23N28-N39N41-N64N80-N98),8725,48.5,3354
Male,2020 **,All other diseases (Residual) (D65-E07E15-E34E65-F99G04-G12G23-G25G31-H93K00-K22K29-K31K50-K66K71-K72K75-K76K83-M99N13.0-N13.5N13.7-N13.9N14N15.0N15.8-N15.9N20-N23N28-N39N41-N64N80-N98),6402,100.2,3357
Male,2021 **,All other diseases (Residual) (D65-E07E15-E34E65-F99G04-G12G23-G25G31-H93K00-K22K29-K31K50-K66K71-K72K75-K76K83-M99N13.0-N13.5N13.7-N13.9N14N15.0N15.8-N15.9N20-N23N28-N39N41-N64N80-N98),10,0.2,3360
Male,Total,All other diseases (Residual) (D65-E07E15-E34E65-F99G04-G12G23-G25G31-H93K00-K22K29-K31K50-K66K71-K72K75-K76K83-M99N13.0-N13.5N13.7-N13.9N14N15.0N15.8-N15.9N20-N23N28-N39N41-N64N80-N98),6412,50.2,3363
Unknown,2020 **,All other diseases (Residual) (D65-E07E15-E34E65-F99G04-G12G23-G25G31-H93K00-K22K29-K31K50-K66K71-K72K75-K76K83-M99N13.0-N13.5N13.7-N13.9N14N15.0N15.8-N15.9N20-N23N28-N39N41-N64N80-N98),0,N/A,3366
Unknown,2021 **,All other diseases (Residual) (D65-E07E15-E34E65-F99G04-G12G23-G25G31-H93K00-K22K29-K31K50-K66K71-K72K75-K76K83-M99N13.0-N13.5N13.7-N13.9N14N15.0N15.8-N15.9N20-N23N28-N39N41-N64N80-N98),0,N/A,3369
Unknown,Total,All other diseases (Residual) (D65-E07E15-E34E65-F99G04-G12G23-G25G31-H93K00-K22K29-K31K50-K66K71-K72K75-K76K83-M99N13.0-N13.5N13.7-N13.9N14N15.0N15.8-N15.9N20-N23N28-N39N41-N64N80-N98),0,N/A,3372
Total,2020 **,All other diseases (Residual) (D65-E07E15-E34E65-F99G04-G12G23-G25G31-H93K00-K22K29-K31K50-K66K71-K72K75-K76K83-M99N13.0-N13.5N13.7-N13.9N14N15.0N15.8-N15.9N20-N23N28-N39N41-N64N80-N98),15119,99.4,3375
Total,2021 **,All other diseases (Residual) (D65-E07E15-E34E65-F99G04-G12G23-G25G31-H93K00-K22K29-K31K50-K66K71-K72K75-K76K83-M99N13.0-N13.5N13.7-N13.9N14N15.0N15.8-N15.9N20-N23N28-N39N41-N64N80-N98),18,0.1,3378
Total,Total,All other diseases (Residual) (D65-E07E15-E34E65-F99G04-G12G23-G25G31-H93K00-K22K29-K31K50-K66K71-K72K75-K76K83-M99N13.0-N13.5N13.7-N13.9N14N15.0N15.8-N15.9N20-N23N28-N39N41-N64N80-N98),15137,49.8,3381
Female,2020 **,Motor vehicle accidents (V02-V04V09.0V09.2V12-V14V19.0-V19.2V19.4-V19.6V20-V79V80.3-V80.5V81.0-V81.1V82.0-V82.1V83-V86V87.0-V87.8V88.0-V88.8V89.0V89.2),322,5.3,3384
Female,2021 **,Motor vehicle accidents (V02-V04V09.0V09.2V12-V14V19.0-V19.2V19.4-V19.6V20-V79V80.3-V80.5V81.0-V81.1V82.0-V82.1V83-V86V87.0-V87.8V88.0-V88.8V89.0V89.2),0,N/A,3387
Female,Total,Motor vehicle accidents (V02-V04V09.0V09.2V12-V14V19.0-V19.2V19.4-V19.6V20-V79V80.3-V80.5V81.0-V81.1V82.0-V82.1V83-V86V87.0-V87.8V88.0-V88.8V89.0V89.2),322,2.7,3390
Male,2020 **,Motor vehicle accidents (V02-V04V09.0V09.2V12-V14V19.0-V19.2V19.4-V19.6V20-V79V80.3-V80.5V81.0-V81.1V82.0-V82.1V83-V86V87.0-V87.8V88.0-V88.8V89.0V89.2),770,13.3,3393
Male,2021 **,Motor vehicle accidents (V02-V04V09.0V09.2V12-V14V19.0-V19.2V19.4-V19.6V20-V79V80.3-V80.5V81.0-V81.1V82.0-V82.1V83-V86V87.0-V87.8V88.0-V88.8V89.0V89.2),0,N/A,3396
Male,Total,Motor vehicle accidents (V02-V04V09.0V09.2V12-V14V19.0-V19.2V19.4-V19.6V20-V79V80.3-V80.5V81.0-V81.1V82.0-V82.1V83-V86V87.0-V87.8V88.0-V88.8V89.0V89.2),770,6.6,3399
Unknown,2020 **,Motor vehicle accidents (V02-V04V09.0V09.2V12-V14V19.0-V19.2V19.4-V19.6V20-V79V80.3-V80.5V81.0-V81.1V82.0-V82.1V83-V86V87.0-V87.8V88.0-V88.8V89.0V89.2),0,N/A,3402
Unknown,2021 **,Motor vehicle accidents (V02-V04V09.0V09.2V12-V14V19.0-V19.2V19.4-V19.6V20-V79V80.3-V80.5V81.0-V81.1V82.0-V82.1V83-V86V87.0-V87.8V88.0-V88.8V89.0V89.2),0,N/A,3405
Unknown,Total,Motor vehicle accidents (V02-V04V09.0V09.2V12-V14V19.0-V19.2V19.4-V19.6V20-V79V80.3-V80.5V81.0-V81.1V82.0-V82.1V83-V86V87.0-V87.8V88.0-V88.8V89.0V89.2),0,N/A,3408
Total,2020 **,Motor vehicle accidents (V02-V04V09.0V09.2V12-V14V19.0-V19.2V19.4-V19.6V20-V79V80.3-V80.5V81.0-V81.1V82.0-V82.1V83-V86V87.0-V87.8V88.0-V88.8V89.0V89.2),1092,9.2,3411
Total,2021 **,Motor vehicle accidents (V02-V04V09.0V09.2V12-V14V19.0-V19.2V19.4-V19.6V20-V79V80.3-V80.5V81.0-V81.1V82.0-V82.1V83-V86V87.0-V87.8V88.0-V88.8V89.0V89.2),0,N/A,3414
Total,Total,Motor vehicle accidents (V02-V04V09.0V09.2V12-V14V19.0-V19.2V19.4-V19.6V20-V79V80.3-V80.5V81.0-V81.1V82.0-V82.1V83-V86V87.0-V87.8V88.0-V88.8V89.0V89.2),1092,4.6,3417
Female,2020 **,Other land transport accidents (V01V05-V06V09.1V09.3-V09.9V10-V11V15-V18V19.3V19.8-V19.9V80.0-V80.2V80.6-V80.9V81.2-V81.9V82.2-V82.9V87.9V88.9V89.1V89.3V89.9),4,N/A,3420
Female,2021 **,Other land transport accidents (V01V05-V06V09.1V09.3-V09.9V10-V11V15-V18V19.3V19.8-V19.9V80.0-V80.2V80.6-V80.9V81.2-V81.9V82.2-V82.9V87.9V88.9V89.1V89.3V89.9),0,N/A,3423
Female,Total,Other land transport accidents (V01V05-V06V09.1V09.3-V09.9V10-V11V15-V18V19.3V19.8-V19.9V80.0-V80.2V80.6-V80.9V81.2-V81.9V82.2-V82.9V87.9V88.9V89.1V89.3V89.9),4,N/A,3426
Male,2020 **,Other land transport accidents (V01V05-V06V09.1V09.3-V09.9V10-V11V15-V18V19.3V19.8-V19.9V80.0-V80.2V80.6-V80.9V81.2-V81.9V82.2-V82.9V87.9V88.9V89.1V89.3V89.9),18,0.3,3429
Male,2021 **,Other land transport accidents (V01V05-V06V09.1V09.3-V09.9V10-V11V15-V18V19.3V19.8-V19.9V80.0-V80.2V80.6-V80.9V81.2-V81.9V82.2-V82.9V87.9V88.9V89.1V89.3V89.9),0,N/A,3432
Male,Total,Other land transport accidents (V01V05-V06V09.1V09.3-V09.9V10-V11V15-V18V19.3V19.8-V19.9V80.0-V80.2V80.6-V80.9V81.2-V81.9V82.2-V82.9V87.9V88.9V89.1V89.3V89.9),18,0.1,3435
Unknown,2020 **,Other land transport accidents (V01V05-V06V09.1V09.3-V09.9V10-V11V15-V18V19.3V19.8-V19.9V80.0-V80.2V80.6-V80.9V81.2-V81.9V82.2-V82.9V87.9V88.9V89.1V89.3V89.9),0,N/A,3438
Unknown,2021 **,Other land transport accidents (V01V05-V06V09.1V09.3-V09.9V10-V11V15-V18V19.3V19.8-V19.9V80.0-V80.2V80.6-V80.9V81.2-V81.9V82.2-V82.9V87.9V88.9V89.1V89.3V89.9),0,N/A,3441
Unknown,Total,Other land transport accidents (V01V05-V06V09.1V09.3-V09.9V10-V11V15-V18V19.3V19.8-V19.9V80.0-V80.2V80.6-V80.9V81.2-V81.9V82.2-V82.9V87.9V88.9V89.1V89.3V89.9),0,N/A,3444
Total,2020 **,Other land transport accidents (V01V05-V06V09.1V09.3-V09.9V10-V11V15-V18V19.3V19.8-V19.9V80.0-V80.2V80.6-V80.9V81.2-V81.9V82.2-V82.9V87.9V88.9V89.1V89.3V89.9),22,0.2,3447
Total,2021 **,Other land transport accidents (V01V05-V06V09.1V09.3-V09.9V10-V11V15-V18V19.3V19.8-V19.9V80.0-V80.2V80.6-V80.9V81.2-V81.9V82.2-V82.9V87.9V88.9V89.1V89.3V89.9),0,N/A,3450
Total,Total,Other land transport accidents (V01V05-V06V09.1V09.3-V09.9V10-V11V15-V18V19.3V19.8-V19.9V80.0-V80.2V80.6-V80.9V81.2-V81.9V82.2-V82.9V87.9V88.9V89.1V89.3V89.9),22,0.1,3453
Female,2020 **,Water air and space and other and unspecified transport accidents and their sequelae (V90-V99Y85),6,N/A,3456
Female,2021 **,Water air and space and other and unspecified transport accidents and their sequelae (V90-V99Y85),0,N/A,3459
Female,Total,Water air and space and other and unspecified transport accidents and their sequelae (V90-V99Y85),6,N/A,3462
Male,2020 **,Water air and space and other and unspecified transport accidents and their sequelae (V90-V99Y85),30,0.5,3465
Male,2021 **,Water air and space and other and unspecified transport accidents and their sequelae (V90-V99Y85),0,N/A,3468
Male,Total,Water air and space and other and unspecified transport accidents and their sequelae (V90-V99Y85),30,0.3,3471
Unknown,2020 **,Water air and space and other and unspecified transport accidents and their sequelae (V90-V99Y85),0,N/A,3474
Unknown,2021 **,Water air and space and other and unspecified transport accidents and their sequelae (V90-V99Y85),0,N/A,3477
Unknown,Total,Water air and space and other and unspecified transport accidents and their sequelae (V90-V99Y85),0,N/A,3480
Total,2020 **,Water air and space and other and unspecified transport accidents and their sequelae (V90-V99Y85),36,0.3,3483
Total,2021 **,Water air and space and other and unspecified transport accidents and their sequelae (V90-V99Y85),0,N/A,3486
Total,Total,Water air and space and other and unspecified transport accidents and their sequelae (V90-V99Y85),36,0.2,3489
Female,2020 **,Falls (W00-W19),787,8.4,3492
Female,2021 **,Falls (W00-W19),0,N/A,3495
Female,Total,Falls (W00-W19),787,4.2,3498
Male,2020 **,Falls (W00-W19),720,11.7,3501
Male,2021 **,Falls (W00-W19),0,N/A,3504
Male,Total,Falls (W00-W19),720,5.8,3507
Unknown,2020 **,Falls (W00-W19),0,N/A,3510
Unknown,2021 **,Falls (W00-W19),0,N/A,3513
Unknown,Total,Falls (W00-W19),0,N/A,3516
Total,2020 **,Falls (W00-W19),1507,9.8,3519
Total,2021 **,Falls (W00-W19),0,N/A,3522
Total,Total,Falls (W00-W19),1507,4.9,3525
Female,2020 **,Accidental discharge of firearms (W32-W34),3,N/A,3528
Female,2021 **,Accidental discharge of firearms (W32-W34),0,N/A,3531
Female,Total,Accidental discharge of firearms (W32-W34),3,N/A,3534
Male,2020 **,Accidental discharge of firearms (W32-W34),10,0.2,3537
Male,2021 **,Accidental discharge of firearms (W32-W34),1,N/A,3540
Male,Total,Accidental discharge of firearms (W32-W34),11,0.1,3543
Unknown,2020 **,Accidental discharge of firearms (W32-W34),0,N/A,3546
Unknown,2021 **,Accidental discharge of firearms (W32-W34),0,N/A,3549
Unknown,Total,Accidental discharge of firearms (W32-W34),0,N/A,3552
Total,2020 **,Accidental discharge of firearms (W32-W34),13,0.1,3555
Total,2021 **,Accidental discharge of firearms (W32-W34),1,N/A,3558
Total,Total,Accidental discharge of firearms (W32-W34),14,0.1,3561
Female,2020 **,Accidental drowning and submersion (W65-W74),37,0.6,3564
Female,2021 **,Accidental drowning and submersion (W65-W74),0,N/A,3567
Female,Total,Accidental drowning and submersion (W65-W74),37,0.3,3570
Male,2020 **,Accidental drowning and submersion (W65-W74),84,1.5,3573
Male,2021 **,Accidental drowning and submersion (W65-W74),0,N/A,3576
Male,Total,Accidental drowning and submersion (W65-W74),84,0.7,3579
Unknown,2020 **,Accidental drowning and submersion (W65-W74),0,N/A,3582
Unknown,2021 **,Accidental drowning and submersion (W65-W74),0,N/A,3585
Unknown,Total,Accidental drowning and submersion (W65-W74),0,N/A,3588
Total,2020 **,Accidental drowning and submersion (W65-W74),121,1.0,3591
Total,2021 **,Accidental drowning and submersion (W65-W74),0,N/A,3594
Total,Total,Accidental drowning and submersion (W65-W74),121,0.5,3597
Female,2020 **,Accidental exposure to smoke fire and flames (X00-X09),36,0.5,3600
Female,2021 **,Accidental exposure to smoke fire and flames (X00-X09),0,N/A,3603
Female,Total,Accidental exposure to smoke fire and flames (X00-X09),36,0.3,3606
Male,2020 **,Accidental exposure to smoke fire and flames (X00-X09),49,0.8,3609
Male,2021 **,Accidental exposure to smoke fire and flames (X00-X09),0,N/A,3612
Male,Total,Accidental exposure to smoke fire and flames (X00-X09),49,0.4,3615
Unknown,2020 **,Accidental exposure to smoke fire and flames (X00-X09),0,N/A,3618
Unknown,2021 **,Accidental exposure to smoke fire and flames (X00-X09),0,N/A,3621
Unknown,Total,Accidental exposure to smoke fire and flames (X00-X09),0,N/A,3624
Total,2020 **,Accidental exposure to smoke fire and flames (X00-X09),85,0.6,3627
Total,2021 **,Accidental exposure to smoke fire and flames (X00-X09),0,N/A,3630
Total,Total,Accidental exposure to smoke fire and flames (X00-X09),85,0.3,3633
Female,2020 **,Accidental poisoning and exposure to noxious substances (X40-X49),1299,23.6,3636
Female,2021 **,Accidental poisoning and exposure to noxious substances (X40-X49),0,N/A,3639
Female,Total,Accidental poisoning and exposure to noxious substances (X40-X49),1299,11.8,3642
Male,2020 **,Accidental poisoning and exposure to noxious substances (X40-X49),2808,51.0,3645
Male,2021 **,Accidental poisoning and exposure to noxious substances (X40-X49),0,N/A,3648
Male,Total,Accidental poisoning and exposure to noxious substances (X40-X49),2808,25.5,3651
Unknown,2020 **,Accidental poisoning and exposure to noxious substances (X40-X49),0,N/A,3654
Unknown,2021 **,Accidental poisoning and exposure to noxious substances (X40-X49),0,N/A,3657
Unknown,Total,Accidental poisoning and exposure to noxious substances (X40-X49),0,N/A,3660
Total,2020 **,Accidental poisoning and exposure to noxious substances (X40-X49),4107,37.2,3663
Total,2021 **,Accidental poisoning and exposure to noxious substances (X40-X49),0,N/A,3666
Total,Total,Accidental poisoning and exposure to noxious substances (X40-X49),4107,18.6,3669
Female,2020 **,Other and unspecified nontransport accidents and their sequelae (W20-W31W35-W64W75-W99X10-X39X50-X59Y86),309,3.8,3672
Female,2021 **,Other and unspecified nontransport accidents and their sequelae (W20-W31W35-W64W75-W99X10-X39X50-X59Y86),0,N/A,3675
Female,Total,Other and unspecified nontransport accidents and their sequelae (W20-W31W35-W64W75-W99X10-X39X50-X59Y86),309,1.9,3678
Male,2020 **,Other and unspecified nontransport accidents and their sequelae (W20-W31W35-W64W75-W99X10-X39X50-X59Y86),408,6.6,3681
Male,2021 **,Other and unspecified nontransport accidents and their sequelae (W20-W31W35-W64W75-W99X10-X39X50-X59Y86),1,N/A,3684
Male,Total,Other and unspecified nontransport accidents and their sequelae (W20-W31W35-W64W75-W99X10-X39X50-X59Y86),409,3.3,3687
Unknown,2020 **,Other and unspecified nontransport accidents and their sequelae (W20-W31W35-W64W75-W99X10-X39X50-X59Y86),0,N/A,3690
Unknown,2021 **,Other and unspecified nontransport accidents and their sequelae (W20-W31W35-W64W75-W99X10-X39X50-X59Y86),0,N/A,3693
Unknown,Total,Other and unspecified nontransport accidents and their sequelae (W20-W31W35-W64W75-W99X10-X39X50-X59Y86),0,N/A,3696
Total,2020 **,Other and unspecified nontransport accidents and their sequelae (W20-W31W35-W64W75-W99X10-X39X50-X59Y86),717,5.1,3699
Total,2021 **,Other and unspecified nontransport accidents and their sequelae (W20-W31W35-W64W75-W99X10-X39X50-X59Y86),1,N/A,3702
Total,Total,Other and unspecified nontransport accidents and their sequelae (W20-W31W35-W64W75-W99X10-X39X50-X59Y86),718,2.6,3705
Female,2020 **,Intentional self-harm (suicide) by discharge of firearms (X72-X74),93,1.5,3708
Female,2021 **,Intentional self-harm (suicide) by discharge of firearms (X72-X74),0,N/A,3711
Female,Total,Intentional self-harm (suicide) by discharge of firearms (X72-X74),93,0.8,3714
Male,2020 **,Intentional self-harm (suicide) by discharge of firearms (X72-X74),728,12.1,3717
Male,2021 **,Intentional self-harm (suicide) by discharge of firearms (X72-X74),4,N/A,3720
Male,Total,Intentional self-harm (suicide) by discharge of firearms (X72-X74),732,6.1,3723
Unknown,2020 **,Intentional self-harm (suicide) by discharge of firearms (X72-X74),0,N/A,3726
Unknown,2021 **,Intentional self-harm (suicide) by discharge of firearms (X72-X74),0,N/A,3729
Unknown,Total,Intentional self-harm (suicide) by discharge of firearms (X72-X74),0,N/A,3732
Total,2020 **,Intentional self-harm (suicide) by discharge of firearms (X72-X74),821,6.6,3735
Total,2021 **,Intentional self-harm (suicide) by discharge of firearms (X72-X74),4,N/A,3738
Total,Total,Intentional self-harm (suicide) by discharge of firearms (X72-X74),825,3.3,3741
Female,2020 **,Intentional self-harm (suicide) by other and unspecified means and their sequelae (*U03X60-X71X75-X84Y87.0),176,2.9,3744
Female,2021 **,Intentional self-harm (suicide) by other and unspecified means and their sequelae (*U03X60-X71X75-X84Y87.0),0,N/A,3747
Female,Total,Intentional self-harm (suicide) by other and unspecified means and their sequelae (*U03X60-X71X75-X84Y87.0),176,1.5,3750
Male,2020 **,Intentional self-harm (suicide) by other and unspecified means and their sequelae (*U03X60-X71X75-X84Y87.0),461,8.3,3753
Male,2021 **,Intentional self-harm (suicide) by other and unspecified means and their sequelae (*U03X60-X71X75-X84Y87.0),0,N/A,3756
Male,Total,Intentional self-harm (suicide) by other and unspecified means and their sequelae (*U03X60-X71X75-X84Y87.0),461,4.2,3759
Unknown,2020 **,Intentional self-harm (suicide) by other and unspecified means and their sequelae (*U03X60-X71X75-X84Y87.0),0,N/A,3762
Unknown,2021 **,Intentional self-harm (suicide) by other and unspecified means and their sequelae (*U03X60-X71X75-X84Y87.0),0,N/A,3765
Unknown,Total,Intentional self-harm (suicide) by other and unspecified means and their sequelae (*U03X60-X71X75-X84Y87.0),0,N/A,3768
Total,2020 **,Intentional self-harm (suicide) by other and unspecified means and their sequelae (*U03X60-X71X75-X84Y87.0),637,5.6,3771
Total,2021 **,Intentional self-harm (suicide) by other and unspecified means and their sequelae (*U03X60-X71X75-X84Y87.0),0,N/A,3774
Total,Total,Intentional self-harm (suicide) by other and unspecified means and their sequelae (*U03X60-X71X75-X84Y87.0),637,2.8,3777
Female,2020 **,Assault (homicide) by discharge of firearms (*U01.4X93-X95),118,2.2,3780
Female,2021 **,Assault (homicide) by discharge of firearms (*U01.4X93-X95),0,N/A,3783
Female,Total,Assault (homicide) by discharge of firearms (*U01.4X93-X95),118,1.1,3786
Male,2020 **,Assault (homicide) by discharge of firearms (*U01.4X93-X95),570,10.5,3789
Male,2021 **,Assault (homicide) by discharge of firearms (*U01.4X93-X95),0,N/A,3792
Male,Total,Assault (homicide) by discharge of firearms (*U01.4X93-X95),570,5.2,3795
Unknown,2020 **,Assault (homicide) by discharge of firearms (*U01.4X93-X95),0,N/A,3798
Unknown,2021 **,Assault (homicide) by discharge of firearms (*U01.4X93-X95),0,N/A,3801
Unknown,Total,Assault (homicide) by discharge of firearms (*U01.4X93-X95),0,N/A,3804
Total,2020 **,Assault (homicide) by discharge of firearms (*U01.4X93-X95),688,6.4,3807
Total,2021 **,Assault (homicide) by discharge of firearms (*U01.4X93-X95),0,N/A,3810
Total,Total,Assault (homicide) by discharge of firearms (*U01.4X93-X95),688,3.2,3813
Female,2020 **,Assault (homicide) by other and unspecified means and their sequelae (*U01.0-*U01.3*U01.5-*U01.9*U02X85-X92X96-Y09Y87.1),44,0.8,3816
Female,2021 **,Assault (homicide) by other and unspecified means and their sequelae (*U01.0-*U01.3*U01.5-*U01.9*U02X85-X92X96-Y09Y87.1),0,N/A,3819
Female,Total,Assault (homicide) by other and unspecified means and their sequelae (*U01.0-*U01.3*U01.5-*U01.9*U02X85-X92X96-Y09Y87.1),44,0.4,3822
Male,2020 **,Assault (homicide) by other and unspecified means and their sequelae (*U01.0-*U01.3*U01.5-*U01.9*U02X85-X92X96-Y09Y87.1),86,1.4,3825
Male,2021 **,Assault (homicide) by other and unspecified means and their sequelae (*U01.0-*U01.3*U01.5-*U01.9*U02X85-X92X96-Y09Y87.1),0,N/A,3828
Male,Total,Assault (homicide) by other and unspecified means and their sequelae (*U01.0-*U01.3*U01.5-*U01.9*U02X85-X92X96-Y09Y87.1),86,0.7,3831
Unknown,2020 **,Assault (homicide) by other and unspecified means and their sequelae (*U01.0-*U01.3*U01.5-*U01.9*U02X85-X92X96-Y09Y87.1),0,N/A,3834
Unknown,2021 **,Assault (homicide) by other and unspecified means and their sequelae (*U01.0-*U01.3*U01.5-*U01.9*U02X85-X92X96-Y09Y87.1),0,N/A,3837
Unknown,Total,Assault (homicide) by other and unspecified means and their sequelae (*U01.0-*U01.3*U01.5-*U01.9*U02X85-X92X96-Y09Y87.1),0,N/A,3840
Total,2020 **,Assault (homicide) by other and unspecified means and their sequelae (*U01.0-*U01.3*U01.5-*U01.9*U02X85-X92X96-Y09Y87.1),130,1.1,3843
Total,2021 **,Assault (homicide) by other and unspecified means and their sequelae (*U01.0-*U01.3*U01.5-*U01.9*U02X85-X92X96-Y09Y87.1),0,N/A,3846
Total,Total,Assault (homicide) by other and unspecified means and their sequelae (*U01.0-*U01.3*U01.5-*U01.9*U02X85-X92X96-Y09Y87.1),130,0.5,3849
Female,2020 **,Legal intervention (Y35Y89.0),0,N/A,3852
Female,2021 **,Legal intervention (Y35Y89.0),0,N/A,3855
Female,Total,Legal intervention (Y35Y89.0),0,N/A,3858
Male,2020 **,Legal intervention (Y35Y89.0),9,N/A,3861
Male,2021 **,Legal intervention (Y35Y89.0),0,N/A,3864
Male,Total,Legal intervention (Y35Y89.0),9,N/A,3867
Unknown,2020 **,Legal intervention (Y35Y89.0),0,N/A,3870
Unknown,2021 **,Legal intervention (Y35Y89.0),0,N/A,3873
Unknown,Total,Legal intervention (Y35Y89.0),0,N/A,3876
Total,2020 **,Legal intervention (Y35Y89.0),9,N/A,3879
Total,2021 **,Legal intervention (Y35Y89.0),0,N/A,3882
Total,Total,Legal intervention (Y35Y89.0),9,N/A,3885
Female,2020 **,Discharge of firearms undetermined intent (Y22-Y24),1,N/A,3888
Female,2021 **,Discharge of firearms undetermined intent (Y22-Y24),0,N/A,3891
Female,Total,Discharge of firearms undetermined intent (Y22-Y24),1,N/A,3894
Male,2020 **,Discharge of firearms undetermined intent (Y22-Y24),10,0.2,3897
Male,2021 **,Discharge of firearms undetermined intent (Y22-Y24),0,N/A,3900
Male,Total,Discharge of firearms undetermined intent (Y22-Y24),10,0.1,3903
Unknown,2020 **,Discharge of firearms undetermined intent (Y22-Y24),0,N/A,3906
Unknown,2021 **,Discharge of firearms undetermined intent (Y22-Y24),0,N/A,3909
Unknown,Total,Discharge of firearms undetermined intent (Y22-Y24),0,N/A,3912
Total,2020 **,Discharge of firearms undetermined intent (Y22-Y24),11,0.1,3915
Total,2021 **,Discharge of firearms undetermined intent (Y22-Y24),0,N/A,3918
Total,Total,Discharge of firearms undetermined intent (Y22-Y24),11,0.0,3921
Female,2020 **,Other and unspecified events of undetermined intent and their sequelae (Y10-Y21Y25-Y34Y87.2Y89.9),21,0.3,3924
Female,2021 **,Other and unspecified events of undetermined intent and their sequelae (Y10-Y21Y25-Y34Y87.2Y89.9),0,N/A,3927
Female,Total,Other and unspecified events of undetermined intent and their sequelae (Y10-Y21Y25-Y34Y87.2Y89.9),21,0.2,3930
Male,2020 **,Other and unspecified events of undetermined intent and their sequelae (Y10-Y21Y25-Y34Y87.2Y89.9),42,0.8,3933
Male,2021 **,Other and unspecified events of undetermined intent and their sequelae (Y10-Y21Y25-Y34Y87.2Y89.9),0,N/A,3936
Male,Total,Other and unspecified events of undetermined intent and their sequelae (Y10-Y21Y25-Y34Y87.2Y89.9),42,0.4,3939
Unknown,2020 **,Other and unspecified events of undetermined intent and their sequelae (Y10-Y21Y25-Y34Y87.2Y89.9),0,N/A,3942
Unknown,2021 **,Other and unspecified events of undetermined intent and their sequelae (Y10-Y21Y25-Y34Y87.2Y89.9),0,N/A,3945
Unknown,Total,Other and unspecified events of undetermined intent and their sequelae (Y10-Y21Y25-Y34Y87.2Y89.9),0,N/A,3948
Total,2020 **,Other and unspecified events of undetermined intent and their sequelae (Y10-Y21Y25-Y34Y87.2Y89.9),63,0.5,3951
Total,2021 **,Other and unspecified events of undetermined intent and their sequelae (Y10-Y21Y25-Y34Y87.2Y89.9),0,N/A,3954
Total,Total,Other and unspecified events of undetermined intent and their sequelae (Y10-Y21Y25-Y34Y87.2Y89.9),63,0.3,3957
Female,2020 **,Operations of war and their sequelae (Y36Y89.1),0,N/A,3960
Female,2021 **,Operations of war and their sequelae (Y36Y89.1),0,N/A,3963
Female,Total,Operations of war and their sequelae (Y36Y89.1),0,N/A,3966
Male,2020 **,Operations of war and their sequelae (Y36Y89.1),1,N/A,3969
Male,2021 **,Operations of war and their sequelae (Y36Y89.1),0,N/A,3972
Male,Total,Operations of war and their sequelae (Y36Y89.1),1,N/A,3975
Unknown,2020 **,Operations of war and their sequelae (Y36Y89.1),0,N/A,3978
Unknown,2021 **,Operations of war and their sequelae (Y36Y89.1),0,N/A,3981
Unknown,Total,Operations of war and their sequelae (Y36Y89.1),0,N/A,3984
Total,2020 **,Operations of war and their sequelae (Y36Y89.1),1,N/A,3987
Total,2021 **,Operations of war and their sequelae (Y36Y89.1),0,N/A,3990
Total,Total,Operations of war and their sequelae (Y36Y89.1),1,N/A,3993
Female,2020 **,Complications of medical and surgical care (Y40-Y84Y88),110,1.3,3996
Female,2021 **,Complications of medical and surgical care (Y40-Y84Y88),0,N/A,3999
Female,Total,Complications of medical and surgical care (Y40-Y84Y88),110,0.7,4002
Male,2020 **,Complications of medical and surgical care (Y40-Y84Y88),114,1.8,4005
Male,2021 **,Complications of medical and surgical care (Y40-Y84Y88),0,N/A,4008
Male,Total,Complications of medical and surgical care (Y40-Y84Y88),114,0.9,4011
Unknown,2020 **,Complications of medical and surgical care (Y40-Y84Y88),0,N/A,4014
Unknown,2021 **,Complications of medical and surgical care (Y40-Y84Y88),0,N/A,4017
Unknown,Total,Complications of medical and surgical care (Y40-Y84Y88),0,N/A,4020
Total,2020 **,Complications of medical and surgical care (Y40-Y84Y88),224,1.5,4023
Total,2021 **,Complications of medical and surgical care (Y40-Y84Y88),0,N/A,4026
Total,Total,Complications of medical and surgical care (Y40-Y84Y88),224,0.8,4029
Female,2020 **,Total,67465,774.8,4032
Female,2021 **,Total,742,8.2,4035
Female,Total,Total,68207,391.5,4038
Male,2020 **,Total,70712,1102.9,4041
Male,2021 **,Total,790,12.3,4044
Male,Total,Total,71502,557.6,4047
Unknown,2020 **,Total,1,N/A,4050
Unknown,2021 **,Total,0,N/A,4053
Unknown,Total,Total,1,N/A,4056
Total,2020 **,Total,138178,923.9,4059
Total,2021 **,Total,1532,10.1,4062
Total,Total,Total,139710,467.0,4065
